WO2014104338A1 - Chemical liquid circuit and chemical liquid system using same - Google Patents

Chemical liquid circuit and chemical liquid system using same Download PDF

Info

Publication number
WO2014104338A1
WO2014104338A1 PCT/JP2013/085207 JP2013085207W WO2014104338A1 WO 2014104338 A1 WO2014104338 A1 WO 2014104338A1 JP 2013085207 W JP2013085207 W JP 2013085207W WO 2014104338 A1 WO2014104338 A1 WO 2014104338A1
Authority
WO
WIPO (PCT)
Prior art keywords
line
syringe
chemical
liquid
physiological saline
Prior art date
Application number
PCT/JP2013/085207
Other languages
French (fr)
Japanese (ja)
Inventor
根本 茂
増田 和正
宗仁 栗本
Original Assignee
株式会社根本杏林堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社根本杏林堂 filed Critical 株式会社根本杏林堂
Priority to JP2014554610A priority Critical patent/JPWO2014104338A1/en
Publication of WO2014104338A1 publication Critical patent/WO2014104338A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M2039/0009Assemblies therefor designed for particular applications, e.g. contrast or saline injection, suction or irrigation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/28Clamping means for squeezing flexible tubes, e.g. roller clamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/28Clamping means for squeezing flexible tubes, e.g. roller clamps
    • A61M39/286Wedge clamps, e.g. roller clamps with inclined guides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14212Pumping with an aspiration and an expulsion action
    • A61M5/14216Reciprocating piston type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14526Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons the piston being actuated by fluid pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/148Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/1684Monitoring, detecting, signalling or eliminating infusion flow anomalies by detecting the amount of infusate remaining, e.g. signalling end of infusion
    • A61M5/16845Monitoring, detecting, signalling or eliminating infusion flow anomalies by detecting the amount of infusate remaining, e.g. signalling end of infusion by weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/36Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
    • A61M5/365Air detectors

Definitions

  • the present invention relates to a chemical circuit and a system for injecting a chemical such as a contrast medium and physiological saline into a patient, and in particular, a chemical circuit and a chemical circuit system that can be suitably used for angiography such as cardiac catheter examination.
  • a chemical circuit and a chemical circuit system that can be suitably used for angiography such as cardiac catheter examination.
  • Medical diagnostic imaging devices include CT (Computed Tomography) scanners and MRI (Magnetic Resonance). There are an imaging device, a PET (Positron Emission Tomography) device, an angiography device, and an MRA (MR Angio) device. When taking an image of a patient using these devices, a medical solution such as a contrast medium or physiological saline is often injected into the patient.
  • CT Computer Tomography
  • MRI Magnetic Resonance
  • Patent Document 1 discloses a chemical circuit system used for angiography (for example, FIGS. 7A to 7B). This system draws a contrast agent source solution connected to a solution circuit into a syringe and injects it toward a patient.
  • the present invention has been made in view of such problems, and an object thereof is to provide a chemical circuit and a chemical circuit system capable of injecting a predetermined chemical liquid in a predetermined procedure without requiring a complicated operation by an operator. There is to do.
  • a chemical circuit is as follows: A contrast agent line connected to the contrast agent chamber; A saline line connected to the saline chamber; A syringe line connected to the chemical syringe; A patient line for delivering contrast media or saline to the patient; A baseline part to which each line is connected; A liquid medicine circuit that is used for liquid medicine injection for injecting a contrast medium into the liquid medicine syringe and then injecting the contrast medium from the syringe toward a patient, further, (I) When the liquid is drawn toward the upstream side of the baseline portion, the contrast medium flows from the contrast agent line into the baseline portion, and (ii) the liquid flows from the upstream side of the baseline portion.
  • a first valve device that allows liquid to flow from the upstream side of the baseline portion to the downstream side without backflowing into the contrast agent line when pushed toward the downstream side;
  • a second valve device that allows liquid to flow from the saline line side to the baseline portion side but not vice versa;
  • a chemical circuit that allows liquid to flow from the saline line side to the baseline portion side but not vice versa;
  • Connected includes not only a predetermined element directly connected to an object but also a state in which the predetermined element is connected through some other element.
  • the “(contrast / saline) chamber” is intended to be a container such as a bottle or a bag, and is not limited to a specific shape.
  • Line (contrast line / saline line / syringe line / patient line, etc.)” means a liquid flow path, and does not necessarily mean that an independent member such as a tube is required. . For example, when a predetermined connector is provided in the baseline portion and a chemical syringe is directly connected to this connector (no tube is used), a part of the connector corresponds to the syringe line. It will be.
  • FIG. 1 It is a figure which shows a part of process of an angiography (extrusion of a contrast agent). It is a figure which shows a part of process of an angiography (flush with the physiological saline). It is a figure which shows a part of process of an angiography (additional flash). It is a figure which shows a part of process of angiography (establishment of a blood route). It is a figure which shows typically the chemical
  • FIG. 14B is a drawing showing a part of the release valve of FIG. 14A. It is sectional drawing which shows an example of a release valve. It is a figure which shows typically the chemical
  • a chemical circuit system 200 is used for, for example, cardiac catheter examination.
  • the chemical circuit system 200 includes a chemical circuit 201 (detailed below), a contrast medium chamber 221, a physiological saline chamber 223, a pressure transducer 270, and a chemical syringe 251 connected thereto.
  • the chemical circuit system 200 also includes an injection head 260 that holds the syringe 251 and sucks and pushes out the chemical (only a part of the injection circuit 260 is also illustrated).
  • the drug solution circuit 201 of FIG. 1 includes a syringe line 204 connected to the syringe 251, a contrast agent line 205 connected to the contrast agent chamber 221, and physiological saline connected to the physiological saline chamber 223.
  • the material, length, and diameter of the tubes constituting the lines 204 to 208 may be appropriately selected in consideration of the pressure applied to the tubes.
  • a portion to which a high pressure is applied is preferably composed of a high pressure resistant tube.
  • dual check valves 215A and 215B and release valves 202A and 202B which will be described later, preferably have a high breakdown voltage.
  • the “baseline part 210” refers to a part to which the above-mentioned lines 204 to 208 are connected as shown in FIG. 1, and is composed of tubes, valves, connectors and the like.
  • the syringe line 204 is connected to the upstream side of the baseline part 210 and the patient line 208 is connected to the downstream side.
  • a contrast medium line 205, a physiological saline line 206, and a transducer line 207 are connected to an intermediate portion of the base line portion 210 sequentially from the upstream side.
  • Each of these lines 205 to 207 is connected to the base line portion 210 in a T shape.
  • the contrast medium line 205 and the physiological saline line 206 are connected to the base line unit 210 by dual check valves 215A and 215B, respectively.
  • the two dual check valves 215A, B may be the same, or different ones having different functions may be used. In FIG. 1, the same thing is utilized as an example.
  • the dual check valves 215A and 215B are valves having the following functions (see also FIG. 2A): (I) When the liquid is drawn toward the upstream side of the baseline portion 210 (that is, the syringe 251 side), the liquid is allowed to flow in that direction. (Ii) On the other hand, regarding the dual check valve 215A, when the liquid is pushed from the upstream side to the downstream side of the baseline part 210, the liquid flows through the valve 215A to the downstream side. As for the dual check valve 215B, when the liquid is similarly pushed toward the downstream side or when being pushed from the physiological saline line 206 side toward the valve 215B side, the liquid flows in those directions. .
  • the dual check valves 215A and 215B restrict the flow from the downstream side to the upstream side and the flow toward the lines 205 and 206 as shown in FIG. 2A.
  • valve 215A is arranged upstream of the dual check valve 215B, and the flow of the liquid upstream is restricted by this valve 215A. It is not pulled toward the side.
  • the transducer line 207 is connected to the base line part 210 by a T-shaped connector 217 having no valve function as an example.
  • a three-way cock 213 may be provided between the T-shaped connector 217 and the dual check valve 215B.
  • the arrangement position of the three-way cock 213 is not necessarily limited to this.
  • the stopcock 213 may be disposed downstream of the air sensor 232 (detailed below) in the patient line 208.
  • the three-way stopcock 213 is one in which one of the three lines connected thereto is closed along the direction of the lever (for example, in the state of FIG. 1, the liquid moves to a line (not shown) that extends downward) May be prevented).
  • a three-way cock is used when an operator discharges the liquid in the line to the outside as needed.
  • the chemical syringe 251 to which the syringe line 204 is connected may have a capacity of, for example, about several tens to 200 ml. Moreover, it is preferable that the syringe 251 can perform high-pressure injection when performing a cardiac catheter test or the like. If necessary, a protective cover that covers the syringe 251 may be used.
  • the syringe 251 has a cylindrical cylinder member and a piston member (plunger rod) that is slidably inserted into the cylinder member.
  • the piston member may be a so-called rodless type.
  • the injector (injection head) 260 to which the chemical syringe 251 is detachably mounted is not limited, but is preferably a type that can perform high-pressure injection, for example.
  • the injector 260 includes a motor that is a driving source and a presser member that moves back and forth. By pulling the presser member, the piston member of the syringe is pulled to fill the syringe with the chemical solution, while by pressing the presser member, the liquid in the syringe is pushed out.
  • the injector 260 may be a one-cylinder type in which only one syringe is mounted, or a two-cylinder type in which only two syringes are mounted. Further, an injector for CT inspection, an injector for MR inspection, an injector for angiography inspection, and the like may be used.
  • a console may be connected to the injector (injection head) 260, and a chemical
  • the console can be connected to the injector 260 in a wired or wireless manner.
  • the console may have one or a plurality of displays and a control unit (control unit, controller) including a microprocessor or the like.
  • This display may be a touch panel type as an example.
  • the piston drive mechanism may have a shaft that receives power from a drive source (not shown) such as a motor and rotates forward and backward on the spot. When this shaft is rotated a predetermined number of times, the presser member (ram member) moves in the front-rear direction by a distance corresponding thereto.
  • a load cell (pressure sensor) for detecting a pressing force applied to the piston may be attached to the pressing surface of the ram member. A method of detecting the pressing force based on the value of the motor current can also be adopted.
  • the syringe outer cylinder (cylinder member) may be made of a resin material such as polyethylene or polypropylene, or made of glass. Also good. It is preferable that at least a portion of the syringe outer cylinder in which the chemical solution is stored has a light-transmitting property, that is, is transparent or translucent so that the remaining amount of the chemical solution inside can be visually recognized. And it is preferable to attach the scale (not shown) which can display the residual amount of a chemical
  • the gasket of the syringe (the tip portion of the piston member) slides in a liquid-tight manner in the axial direction within the syringe outer cylinder, and at least the outer peripheral portion thereof may be formed of an elastic seal member.
  • the contrast agent chamber 221 to which the contrast agent line 205 is connected may be a bottle-like container filled with a contrast agent.
  • the contrast agent chamber 221 may be used while being suspended by a suspender (not shown), and the contrast agent line 205 is connected to the lower portion of the contrast agent chamber 221. This connection may be made via a needle.
  • an air sensor 231 for example, an infrared sensor for detecting whether air is mixed in the liquid in the contrast medium line 205 is disposed below the contrast medium chamber 221.
  • a drip chamber 233 is disposed below the air sensor 231 and on the contrast medium line 205, and the contrast medium from the contrast medium chamber 221 once drops into the chamber 233, and the contrast medium from within the chamber 233. It flows into the line 205.
  • the physiological saline chamber 223 to which the physiological saline line 206 is connected may be a bag-like container filled with physiological saline, and in this example, further, a pressurizing means 224 for pressurizing the bag.
  • a pressurizing means 224 for pressurizing the bag.
  • the pressurizing means 224 is not limited, and may compress the bag using a fluid such as air as a driving source, or compress the bag using a motor or the like as a driving source. Also good.
  • a similar air sensor 231 and drip chamber 233 are also disposed in the physiological saline line 206.
  • the mechanism for pressurizing the physiological saline is not limited to the above, but other configurations will be described later.
  • the physiological saline line 206 is provided with a release valve 202A for switching opening and closing of the line 206.
  • the release valve 202A has a movable member 203 that moves in response to an external force. By moving the movable member 203, the valve opening / closing state is switched to open and close the physiological saline line 206.
  • the valve 202A is opened by pushing the movable member 203, and physiological saline from the pressurized bag flows toward the baseline portion 210 (the direction in which the liquid flows depends on the pressure difference of the liquid). It is configured as follows.
  • the pressure transducer 270 connected to the line 207 detects blood pressure so that the patient's pulse can be monitored.
  • the pulse waveform is configured to be displayed on a display 271 connected to the transducer 270.
  • the transducer valve 207 is also provided with a release valve 202B similar to the release valve 202A of the physiological saline line 206. However, the direction is opposite to that of the release valve 202A. In this release valve 202B, the movable member 203 is pushed, so that the chemical liquid can flow to the transducer 270 side.
  • the movable member 203 of one release valve 202A and the movable member 203 of the other release valve 202B are arranged to face each other. Furthermore, the distance (L1, L2) from the base line part 210 to the movable members 203, 203 of each valve is arranged so as not to be the same so as to correspond to the configuration of the switching machine 300 described later.
  • a thin tube called a catheter (not shown) is connected to the distal end of the patient line 208, and this catheter is inserted into the patient's blood vessel.
  • the catheter tip is transferred to, for example, the coronary artery, and a contrast agent or the like is injected into the blood vessel from the catheter tip.
  • the switching machine 300 includes a box-shaped housing 310 as an example.
  • the switching device 300 includes a first holding unit 306 for holding a part of the physiological saline line 206 and a second holding unit 307 for holding a part of the transducer line 207. These holding portions 306 and 307 are formed in a concave shape, and the release valves 202A and 202B of each line are set therein.
  • driving units 301 and 301 that push the movable members 203 and 203 of the valves 202A and 202B electromechanically using, for example, a motor as a driving source are provided.
  • the driving units 301 and 301 may be configured to operate in response to a control signal from an external controller 350.
  • the function of the controller 350 is not particularly limited, but the injector 260 may have the function.
  • the switching machine 300 also includes a third holding unit 308 that holds a part of the patient line 208 and an air sensor 332 that detects the presence or absence of bubbles in the patient line 208.
  • the air sensor 332 may be an ultrasonic sensor.
  • the ultrasonic sensor 332 is advantageous in that, even when bubbles are mixed in the liquid under a high pressure condition, the ultrasonic sensor 332 can be found well.
  • FIG. 3 shows an initial state.
  • the movable members 203 and 203 of the release valves 202A and 202B are not pushed and the liquid does not flow bidirectionally.
  • the piston drive mechanism operates to pull the piston member of the syringe 251.
  • the inside of the syringe 251 and the syringe line 204 becomes negative pressure, and the contrast agent in the chamber 221 is drawn into the syringe lines 205 and 204 and the syringe 251 via the contrast agent line 205 and the dual check valve 215A.
  • the piston member of the syringe 251 is pushed, and the contrast agent is pushed out from the syringe 251.
  • the liquid passes through the syringe line 204 to the baseline part 210 side, passes through the two dual check valves 215A and 215B, and fills the baseline part 210.
  • This extrusion operation of the contrast agent is continued until the contrast agent is pushed out at least beyond the dual check valve 215B, as shown in FIG.
  • the movable member 203 of the release valve 202A and the movable member 203 of the release valve 202B are pushed to open both valves 202A and 202B.
  • the opening is automatically performed when the driving units 301 and 301 of the switching machine 300 press each movable member.
  • the pressurizing means 224 of the physiological saline chamber 223 is driven, and a predetermined pressure (for example, about 300 mmHg) is applied to the physiological saline. Therefore, when the valve 202A is opened, the physiological saline flows from the chamber 223 side toward the base line part 210, passes through the release valve 202A and the dual check valve 215B, and flows toward the patient line 208 side.
  • the contrast agent further passes through the three-way stopcock 213 and branches at the connector 217, with some flowing into the patient line 208 and the other flowing into the transducer line 207.
  • the release valve 202B since the release valve 202B is opened, the physiological saline flows toward the transducer 270 beyond the release valve 202B. In this way, by filling each line with physiological saline, bubbles in the line are removed to the outside.
  • the pressing of the movable member 203 of the release valve 202A of the physiological saline line 206 is released so that the physiological saline does not flow downstream beyond the release valve 202A.
  • the pressing of the movable member 203 of the release valve 202B of the transducer line 207 is released so that the contrast agent does not flow into the transducer 270 side in the next contrast agent injection step, and the contrast agent or the like exceeds the release valve 202B. Make sure that it does not flow to the transducer side.
  • the contrast medium in the syringe 251 is pushed out toward the patient as shown in FIG. Specifically, the contrast agent passes through the contrast agent line 204, the baseline portion 210, the patient line 208, and a catheter (not shown) to a predetermined imaging site (for example, a coronary artery of the heart) in the patient body. Sent.
  • the movable member 203 of the release valve 202A of the physiological saline line 206 is pushed as shown in FIG. 8 to open the valve again.
  • a predetermined pressure for example, about 300 mmHg
  • the pressurizing means 224 of the pressure bag is sent to the base line part 210 and the patient line 208, and the contrast medium is flushed.
  • the release valve 202B of the transducer line 207 is opened, whereby physiological saline is caused to flow further to the transducer side than the release valve 202B. Do a flash by.
  • the chemical circuit 201 includes the contrast medium line 205, the physiological saline line 206, the syringe line 204, the patient line 208, and the base line section 210, and the contrast medium line 205.
  • Dual check valves 215A and 215B for restricting the flow of the liquid in a predetermined direction are provided at a connection portion between the base line portion 210 and the physiological saline line 206 and the base line portion 206. Therefore, it is possible to satisfactorily perform the suction of the contrast medium into the syringe 251 (FIG. 3) and the subsequent delivery of the contrast medium (FIG. 4) without requiring the operator to manually switch the three-way stopcock. Can do.
  • the chemical circuit 201 of this embodiment is provided with a release valve 202A in the physiological saline line 206.
  • the release valve 202A since the release valve 202A switches between opening and closing by pressing the movable member 203, for example, the release valve 202A can be easily switched compared to a type in which opening and closing is switched by twisting a lever such as a three-way cock.
  • a lever such as a three-way cock.
  • there is an advantage that it is easy to perform automatic switching by a switching machine using an actuator such as a motor.
  • such movement of the movable member 203 can be performed in a short time compared to the case of twisting the lever.
  • the closing in the case of the configuration in which the flow path is closed by the function of the release valves 202A and 202B itself as in the present embodiment, for example, the closing can be performed more reliably than when the tube is crushed and closed.
  • the transducer line 207 can be satisfactorily closed using the release valve 202B, so that a high-pressure liquid transducer 270 can be used even when a high-pressure injection such as a cardiac catheter test is performed. Inflow to the side can be prevented, and as a result, breakage and damage of the transducer 270 can be prevented.
  • the drug solution circuit 201 of the present embodiment is used as a disposable with the contrast medium line 205, the physiological saline line 206, the syringe line 204, the transducer line 207, the patient line 208, and the base line unit 210 as one set. It may be a thing. That is, the chemical circuit 201 can be used a plurality of times, but may be replaced with a new one when the use with respect to one patient is completed for the purpose of preventing infection. In this case, it may be disposable including the drip chambers 233 and 233 (only one of them) of the physiological saline line 206 and the contrast medium line 205.
  • the chemical circuit system of the present embodiment uses the chemical circuit 201 described above, and includes an injector that mounts the syringe 251 and performs suction and injection (delivery) of liquid, and opening and closing a predetermined line of the chemical circuit 201. And a switching device 300 that automatically switches between. According to such a system, it is possible to appropriately perform a series of injection operations of contrast medium and physiological saline without requiring the operator to switch the three-way stopcock, and if necessary, all steps Can also be performed automatically.
  • the present invention is not limited to the form described above.
  • a tube pump that continuously crushes the tube and flows physiological saline in the tube in a predetermined direction may be used instead of the pressure bag.
  • a device that repeatedly sucks and pushes physiological saline by reciprocating the piston member of a small syringe can be used.
  • This device uses a cam mechanism and a biasing member (for example, a spring). May be.
  • FIG. 11 shows only a part of the chemical circuit system. About the structure downstream from the three-way cock 213, the thing similar to FIG. 1 can be used.
  • the pump device 226 is of the type disclosed in Japanese Patent No. 3626264, for example.
  • the pump device 226 includes a main body 227 on which a small syringe 226a is mounted, and a piston drive mechanism (not shown) that moves the piston member of the syringe 226a back and forth.
  • T-shaped connectors 215C and 215D are used instead of the dual check valves 215A and 215B, and one valve V-1 is disposed between the two connectors.
  • the one-way valve V-1 is arranged so as to allow the flow to the downstream side and not to allow the flow in the opposite direction, as indicated by the triangular mark in FIG.
  • the flow restriction directions of the other one-way valves V-2 to V4 also follow the direction of the triangular mark in FIG.
  • a connector 234, an infusion chamber 233, an air sensor 231 and a one-way valve V-2 are arranged in this order from the side close to the chamber 221.
  • the arrangement of these components 234, 233, 231 can be changed as appropriate.
  • the physiological saline line 206 connecting the connector 215D and the physiological saline chamber 223 is divided into two on the way, and the branched line 209 extends to the pump device 226.
  • the line 209 is connected to the line 206 by a T-shaped connector.
  • two one-way valves V-3 and V-4 are arranged on the line 206.
  • One one-way valve V-5 is also provided between the connector 215D and the three-way cock 213.
  • the one-way valve V-5 may be omitted.
  • a circuit downstream from the one valve may be made disposable.
  • a circuit downstream from the connector 215D may be used as the disposal regardless of the presence or absence of the one-way valve V-5.
  • a chemical liquid tube (not shown) may be connected to the three-way cock 213, and the chemical liquid may be injected toward the patient via the chemical liquid tube.
  • a load sensor 223 ⁇ / b> S that measures the weight of the physiological saline chamber 223 is provided.
  • the control device (not shown) is based on the output value of the load sensor 223S or a value obtained by converting the load sensor 223S into a load. Whether or not) When it is determined that the value is equal to or less than a predetermined set value, a predetermined warning (for example, lighting of a lamp, display of a message, output of sound or sound, etc.) is issued to the surgeon.
  • load sensor 223S as described above can also be used in the chemical circuit system of the embodiment of FIG.
  • a connector having a floating valve body as disclosed in Japanese Patent Application Laid-Open No. 9-117505 can be used as an example for the drip chamber. , Air contamination on the patient line side is prevented. Further, it may be determined based on the position of the valve body whether or not it is empty, and if it is empty, control such as stopping injection may be performed.
  • the chemical circuit system of FIG. 11 includes the following chemical circuit: A medical chemical circuit used for angiography, A contrast agent line connected to the contrast agent chamber; A saline line connected to the saline chamber; A syringe line connected to the syringe; A patient line for delivering contrast media or saline to the patient; A baseline part to which each line is connected, wherein the contrast medium line and the physiological saline line are each connected in a T-shape; and
  • a (i) When the liquid is drawn toward the upstream side of the baseline portion, the contrast medium flows from the line into the baseline portion, and (ii) the liquid flows from the upstream side of the baseline portion.
  • a first valve means (V-1, V-2) configured to pass through the valve means and flow liquid in that direction when pushed toward the downstream side;
  • Second valve means (V-1) which allows the liquid to flow in the direction when the liquid is pushed from the upstream side to the downstream side of the baseline portion but does not allow the reverse flow.
  • c When the physiological saline is sent from the physiological saline chamber by the physiological saline feeding means, the physiological saline is allowed to flow to the patient line side, and the flow to the syringe line side is not allowed.
  • Valve means (V-3, V-1);
  • a medical chemical circuit comprising:
  • FIG. 16 shows a chemical circuit and a chemical circuit system according to another embodiment of the present invention.
  • the circuit configuration of FIG. 16 may be basically the same as that of FIG. 11, and is the same as or corresponds to the structural part having the same function as that of FIG. 11 (shown by replacing the 200 series with the 600 series). Are attached).
  • reference numeral 605 is a contrast medium line
  • reference numeral 606 is a physiological saline line
  • reference numeral 607 is a transducer line
  • reference numeral 609 is a line branched from the physiological saline line 606
  • reference numeral 608 is a patient line
  • reference numeral 610 is a baseline.
  • Reference numeral 621 is a contrast medium chamber
  • reference numeral 623 is a physiological saline chamber.
  • Reference numeral 633 denotes an infusion chamber, and the infusion chamber 633 may be a conventionally known one in which an insertion needle is integrally formed thereon.
  • Reference numerals V-1 to V4 denote one-way valves having the same structure and the same arrangement as those in FIG.
  • Reference numerals 615C to 615F denote T-shaped connectors, and reference numerals 641, 642, and 643 denote connection members.
  • at least one of the connectors 615C and 615D may be a dual check valve as described above.
  • the syringe pump 500 has a double packing type syringe 550 (detailed below).
  • the one-way valve V-5 (see FIG. 11) is omitted.
  • a release valve 401A (details below) is arranged on the transducer line 607;
  • a syringe 550 used in the syringe pump 500 (FIG. 16) will be described with reference to FIG.
  • the syringe 550 is a dust-proof syringe as disclosed in, for example, Japanese Patent No. 3639095: A hollow cylinder member 551; A piston member 557 formed with two-stage pistons 553 and 554 that slide in the axial direction in the cylinder member 551; Having Annular seal members R1 and R2 for ensuring watertightness are provided on the outer periphery of the first and second pistons 553 and 554.
  • the distance between the seal members R1 and R2 may be set to a distance equal to the stroke amount of the first-stage piston 553 necessary for sucking a predetermined injection amount.
  • the material of the seal member is an example, and may be an elastic member such as an elastomer.
  • the piston member 557 sucks a predetermined injection amount at a position (before suction) where the front surface of the first-stage piston 553 contacts or substantially contacts the inner surface of the front end of the cylinder member 551. It is configured to reciprocate between a position moved by a predetermined stroke (after suction).
  • the second-stage piston 554 is disposed behind the first-stage piston 553.
  • the cross-sectional shape of the seal rings R1 and R2 is not particularly limited. For example, various cross-sections such as a circle, an ellipse, a rectangle, a polygon, and a D-shape can be used.
  • a concave portion 577 a that is gripped by a gripping member (not shown) of the syringe pump is formed at the base end portion of the piston member 557.
  • the piston member 557 reciprocates with respect to the cylinder member 551 in response to a force from a drive mechanism (not shown) of the syringe pump.
  • the suction of the chemical liquid to the syringe 550 and the delivery of the chemical liquid from the syringe 550 are repeated to act as a pump.
  • the piston member may be reciprocated using a pump system as disclosed in Japanese Patent No. 4367911.
  • a syringe having a position restriction piece on the cylinder member may be attached to the pump system.
  • the distance between the seal members R1 and R2 is approximately equal to the stroke required for the first-stage piston 553 to suck a predetermined injection amount.
  • the syringe 550 may be modified as follows.
  • the sealing member R1 and / or R2 is provided integrally with the piston, for example by integral molding. -The sealing member R2 is not fitted.
  • the piston prevents foreign matter (such as dust) from entering the inside of the piston.
  • the range from the front surface portion to the outer peripheral portion of the first-stage piston is constituted by an elastic member.
  • the entire at least one piston is made of an elastic member;
  • the space between the pistons 553, 554 is filled with a gas having a sterilizing effect.
  • the distance between the sealing members R1, R2 is set longer or shorter than the stroke of the first stage piston.
  • a wing-like member for preventing rotation may be formed on the outer peripheral surface of the cylindrical cylinder member 551.
  • the injector is operated to suck the contrast agent from the contrast agent chamber 621 into the chemical syringe 651, and An injection operation of pushing the contrast agent toward the patient, and (ii) an operation of operating the syringe pump 500 to inject the physiological saline in the physiological saline chamber 623 toward the patient, such as a stopcock switching operation by an operator Can be carried out correctly without any special requirements.
  • a syringe having a structure like the above-described syringe 550 is used instead of the chemical syringe 651 (having a cylindrical cylinder member and a piston member slidably inserted therein). Also good.
  • the second piston may be configured as shown in FIG.
  • a seal member R2 is attached to the outer periphery of the piston, and a gas passage 558 is formed between a groove 554a formed from the outer periphery of the piston toward the center and the seal member R2.
  • Sterile gas may be sealed between the first piston and the second piston through the gas passage 558.
  • the size of the gas passage 558 can be changed as appropriate, but as an example, it is also preferable that the gas passage 558 has a size that allows gas to be sealed and that foreign matters such as dust hardly pass through.
  • the 18 may be formed with a small hole 554b for enclosing a sterilizing gas. Although only one is shown in FIG. 18, the small hole 554b may be one or more. Both the groove 554a and the small hole 554b may be provided, or only one of them may be provided.
  • FIG. 14A is a cross-sectional view of a release valve used in the configuration of FIG.
  • FIG. 14B is a front view and a bottom view showing the shaft member of the release valve.
  • the release valve 401A includes a hollow main body member 411, a tube connection member 412 connected to a lower portion thereof, and a cap member 413 that closes an upper end opening of the main body member 411 as members constituting the casing 410. ing.
  • a shaft member 425 is disposed inside the main body member 411 so as to be movable upward and downward.
  • the shaft member 425 is provided with two seal members 428 and 429, and a flange portion 425f is formed on a part of the shaft member 425.
  • each of the sealing members 428 and 429 may be a disk-shaped member made of an elastic member.
  • the shaft member 425 is biased upward by the coil spring S1 (FIG. 14), and in this state, the flange portion 425f presses against the seal member 429. In this state, liquid does not flow from the lower end opening 412a of the connection member 412 toward the side opening 411a of the main body member 411 (or in the opposite direction).
  • the flange portion 425f moves downward, so that the liquid flow path (not shown in detail) is opened.
  • the liquid can flow from the lower end opening 412a of the connection member 412 toward the side opening 411a of the main body member 411 (or in the opposite direction).
  • a part of the flow path may be formed by a groove formed along the longitudinal direction of the outer periphery of the shaft member 425.
  • the lower end side 425a of the shaft member 425 has a cross-shaped cross section as an example. The shape is not necessarily limited to a cross shape, and may be changed to various shapes.
  • the shaft member 425 may be pressed / released by using a device such as the automatic switching machine 300 (FIG. 2B) described in the first embodiment.
  • the operation of the switching machine may be controlled by an injection device, or may be manually operated by an operator.
  • a release valve 401B as shown in FIG. 15 may be used.
  • the release valve 401B of FIG. 15 includes a hollow main body member 411 and a cap member 413 that closes the upper end opening as members constituting the casing 410.
  • a shaft member 425 is arranged inside the main body member 411 so as to be movable upward and downward.
  • the shaft member 425 is provided with one seal member 429 and an O-ring R1.
  • a pressing member 416 having a flow path formed therein is attached to the upper end of the shaft member 425 protruding upward from the cap member 413.
  • the pressing member 416 has a side opening 416a serving as a liquid inlet / outlet.
  • circuit configuration according to another embodiment
  • This chemical circuit 601P is partially similar to that of FIG. 11 and FIG. 16 described above, but a part of the circuit is a disposable circuit and a clamping mechanism for closing the tube (line). Is different (details below).
  • the chemical circuit (601P) in the chemical circuit system of FIG. 19 can be expressed as follows as an example: A contrast agent line (605) connected to the contrast agent chamber (621); A saline line (606) connected to a saline chamber (623); A liquid flow path connected to the chemical syringe (651); A patient line (608) for delivering contrast agent or saline to the patient; A baseline portion (610) to which each line is connected; A chemical circuit (601P) used for injecting a contrast medium into the chemical syringe (651) and then injecting the contrast medium from the syringe toward the patient, In addition, it is structured as follows: (I) When the liquid is drawn toward the upstream side of the baseline portion, the contrast agent flows from the contrast agent line into the baseline portion, and (ii) the liquid flows from the upstream side to the downstream side of the baseline portion.
  • the disposable circuit portion (601P-1) on the downstream side of the connection portion between the base line portion (610) and the physiological saline line (606) is preferably detachable via a one-way valve (V-5). It is configured.
  • the disposable circuit portion 601P-1 is configured to be detachable with respect to the end of a line 608 extending downstream from the connector 615D via a one-way valve V-5, a connector, or the like.
  • the one-way valve V-5 is used, but it may be detachable by a simple connector or the like.
  • the disposable circuit portion 601P-1 has a line 608 extending from the one-way valve V-5 toward the patient, and a line 607 branched from the midway position toward the transducer 670.
  • One clamping mechanism 660 is provided at the line 607 and the line 608 of the disposal circuit portion 601P-1.
  • the clamping mechanism 660 may include a drive source (not shown) and one or more clamp members 668 that press the tube.
  • the clamp member 668 is moved by a driving force from a driving source (not shown), and the flexible tube is crushed to close the flow path.
  • the driving source (not shown) is not particularly limited, but various actuators such as a motor and a fluid cylinder can be used.
  • the operation control of the drive source may be automatically performed by a controller (not shown).
  • a controller may be a microcomputer including a processor unit, a memory, and the like, and its arrangement position is not limited at all.
  • the two clamping mechanisms 660 are drawn apart from each other, but these may be driven by different driving sources or driven by a common driving source. There may be.
  • An air sensor 631 is provided in the middle or at the end of the contrast medium line 605, An air sensor 631 is provided in the middle or at the end of the physiological saline line 606; -At least one of the connectors 615C to 615F has the function of a one-way valve (check valve), etc.
  • the air sensor 631 may use infrared rays as exemplified in the above embodiment, but may also be an optical sensor that uses ultraviolet rays, a sensor that uses ultrasonic waves, or the like. .
  • an ultraviolet sensor there is an advantage that it is possible to better distinguish between blood and a chemical solution and to detect a foreign substance in the liquid as compared with an infrared sensor.
  • each clamp member 668a and 668a arranged to face each other with the tube T interposed therebetween are provided.
  • Each clamp member 668 has a corner portion on the side in contact with the tube, and presses the tube at the corner portion.
  • both the clamp members 668a have corners, only one of the clamp members 668a is as shown in the figure, and the other is a clamp member (not shown) that abuts on a flat surface. Also good.
  • the clamp member 668a ′ (FIG. 20B) may have a facing surface having a shape substantially complementary to the corner of the clamp member 668a (in this example, a V-shaped groove as an example).
  • each clamp member 668b protrudes in a curved shape on the side in contact with the tube, and the tube T is pressed by this protruding portion.
  • the other is a flat clamp member (not shown) or a substantially complementary shape (curved concave surface in this example) as described above. It is good also as a clamp member (not shown) which has an opposing surface.
  • each clamp member 668c is formed in a circular shape.
  • the other may be a flat clamp member (not shown), a clamp member (not shown) having a curved concave surface, or the like.
  • the clamp member may have any shape or material as long as it can firmly close the tube.
  • a rod-shaped member for example, a pin clamp; one end of the rod-shaped member serves as an abutting portion for the tube.
  • the tube may be pressed by a part of the outer peripheral surface of the rod-shaped member), a plate-shaped member.
  • Various members such as a block member and a spherical member can be used.
  • the clamp member may be metallic or made of resin. In the case of metallicity, either a magnetic material or a nonmagnetic material may be used.
  • each clamp member may advance toward the center of the tube and sandwich the tube, or may be configured to be movable. Only one of them may advance with respect to the other and sandwich the tube.
  • the mechanism may be a mechanism in which the operation of one clamp member and the operation of the other clamp member are linked with each other.
  • a pair of clamp members are not used, but only one member is movable clamp members 668a to 668c, and the fixed receiving surface 668s on which the clamp members 668a to 668c do not move. It is configured to be able to move forward and backward.
  • the shape of each of the clamp members 668a to 668c is the same as that in FIG.
  • a clamping mechanism configured as shown in FIG. 22 may be used.
  • the clamping mechanism has a slide member 669 that can move in the lateral direction.
  • a predetermined direction rightward in the drawing
  • the clamp member 668 is moved toward the tube T side in contact with 668, and finally the tube T is closed.
  • the clamp member 668 moves backward from the tube T, and the tube T is opened.
  • the slide member 669 may have an inclined surface (cam surface) 669a that contacts the clamp member 688 as a specific example.
  • the slide member 669 may be slid by a user's finger, for example, or may be configured to be automatically slid by a drive mechanism (actuator) (not shown).
  • the moving direction of the slide member 669 is not necessarily limited to the horizontal direction (that is, the direction along the tube in this case). Although illustration is omitted, for example, by rotating in the circumferential direction with respect to the tube, the cam surface formed in a part of the member gradually becomes an internal clamp member (in this case, a sphere may be used as an example). You may press against the tube side.
  • an anti-slip rib and / or a protrusion may be formed on a part of the slide member 669, for example, at a portion where the finger abuts. Further, a receiving part (or engaging part to be engaged) with which a part of the drive mechanism for moving the slide member 669 comes into contact may be formed.
  • a part of the slide member 669 may be engaged or fitted with another member to obtain a click feeling.
  • a part of the slide member 669 may be fitted into a recess (not shown) formed on another member, or may be configured to get over a protrusion formed on the other member.
  • a click feeling is obtained even when the slide member 669 is removed from the fixed position. It goes without saying that such a change can be similarly applied to the configuration of FIG. 23 described below.
  • FIG. 23 As the clamping mechanism, the one shown in FIG. 23 can also be used.
  • the clamping mechanism of FIG. 23 has the same principle as that of FIG. 22 for opening and closing the tube, but a relatively soft tube T ′ disposed in the connector housing (662, detailed below) is provided. The difference is that the clamp member 668 is pressed.
  • One reason for this configuration is as follows.
  • the tube T ′ may be more easily deformed by making the material of the tube softer than that of other tubes of the chemical circuit, or (ii) The material is the same, but the tube T ′ may be more easily deformed by reducing the thickness of the tube T ′, reducing the warp, and / or combinations thereof.
  • the protective cover 662 is provided so as to surround the soft tube T ′.
  • the protective cover 662 may have any shape, but may be a cylindrical shape having an inner diameter that is slightly larger than the diameter of the tube.
  • the cross-sectional shape is preferably circular, but may be, for example, an ellipse, a rectangle, or a polygon.
  • An opening 662a is formed in a part of the protective cover 662, and the clamp member 668 is configured to move forward and backward through the opening 662a.
  • the protective cover 662 may be made of any material, but as an example, the protective cover 662 may be a resin molded product.
  • the tube is crushed well compared to the case of directly pressing a part of the chemical liquid tube T, that is, The line can be closed, which is particularly advantageous in the case of high-pressure chemical solution injection.
  • the chemical solution circuit may be arranged at one or a plurality of locations selected from positions indicated by symbols A to E.
  • each clamping mechanism may be the same or different.
  • a higher-pressure clamping mechanism is arranged at a high pressure
  • a normal clamping mechanism is arranged at a low pressure. You can also.
  • roller-type pump 470 as shown in FIG. 12 can be used as means for pressurizing the chemical chamber and delivering the chemical.
  • the pump 470 includes a pair of pressing members 471 and 472 arranged so as to sandwich the chamber 223 therebetween. When one of the pressing members 471 and 472 comes close to the other, the chamber 223 between both the members 471 and 472 is pressed, and thereby the chemical solution inside the chamber 223 is pushed out.
  • both members may be connected by a hinge portion 474 so that one of the members rotates with respect to the other.
  • a roller 476 may be provided to bring one member close toward the other.
  • the roller 476 rotates around the rotation center 476a (there may or may not be a drive source) and moves downward as indicated by an arrow in the figure, and the pressing member 471 is directed toward the other member 472.
  • You may be comprised so that it may press.
  • a piston type pump 480 as shown in FIG. 13 can be used.
  • the pump 480 includes two syringes 481 and 486 connected in series, and the front end portion of the front syringe 481 is connected to the line 209 (see FIG. 11).
  • a short gasket 482a is slidably disposed in the front syringe 481, and a protrusion 485 is formed on the back surface of the gasket 482a.
  • the protrusion 485 is not necessarily formed, but plays a role of defining a movable range when the gasket 482a moves rearward.
  • the tip of the rear syringe 486 is formed to be thin and inserted into a through hole formed in the sealing member 482b of the front syringe 481.
  • the pump 480 is also provided with driving means (not shown) for moving the piston member of the rear syringe 486 back and forth.
  • an octopus tube may be provided at an arbitrary position of the circuit in order to prevent air bubbles from being injected into the patient.
  • an octopus pipe may be provided between the connector 217 and the air sensor 232 in the configuration of FIG.
  • the “octopus tube” is a protruding part (the outer shape may be any shape) such as the head of a spear that is formed in a hollow inside, and traps bubbles flowing through the circuit. Is to do. Therefore, it is preferable that the octopus pipe is arranged so as to protrude vertically upward. Moreover, it is preferable to provide in the location where the direction of a line (tube) is stable among circuit systems so that the attitude
  • a contrast agent line (605) connected to the contrast agent chamber; A saline line (606) connected to the saline chamber; A syringe line (604) connected to the chemical syringe (651); A patient line (608) for delivering contrast agent or saline to the patient; A baseline portion (610) to which the lines are connected; A chemical liquid circuit (601) used for injecting a contrast medium into the chemical liquid syringe (651) and then injecting the contrast medium from the syringe toward the patient, further, (I) When the liquid is drawn toward the upstream side of the baseline part (610), the contrast agent flows from the contrast medium line (605) into the baseline part (610), and (ii) When the liquid is pushed from the upstream side to the downstream side of the baseline part (610), the liquid flows from the upstream side to the downstream side of the baseline part (610) without flowing back into the contrast agent line.
  • a first valve device (V-1, V-2) that allows the flow of A second valve device
  • a transducer line (607) having one end connected to the pressure transducer and the other end connected to the baseline portion (610);
  • a release valve (401A) having a movable member (425) and disposed on the transducer line (607) and opening and closing the line by moving the movable member (425);
  • the circuit part (601P-1) on the downstream side of the connection part between the base line part and the physiological saline line is preferably configured to be exchangeable via a one-way valve (V-5).
  • a chemical circuit system (600) comprising:
  • the pump unit is A syringe pump (500) for transferring a liquid by repeating an operation of sucking a liquid into a syringe and an operation of pushing out the liquid.
  • the syringe (550) of the syringe pump is A hollow cylinder member (551); A piston member (557) formed with two-stage pistons (553, 554) sliding in the axial direction in the cylinder member (551);
  • the above-described chemical circuit system which is a dust-proof syringe (550) having
  • Seal members (R1, R2) for ensuring water-tightness are provided on the outer periphery of the first-stage and second-stage pistons (553, 554), and between the seal members (R1, R2).
  • the saline line is connected to the saline delivery device, not the chamber.
  • the “physiological saline delivery device” has a certain housing member that contains physiological saline and a mechanism that pushes out the physiological saline. For example, -Aspirate saline from chamber 623 into a generic syringe only once and push saline out of the syringe. A device that does not include the chamber 623 or the syringe pump 500 and simply pushes the physiological saline from a physiological saline containing member (for example, a syringe).
  • the syringe may be a prefilled type pre-filled with physiological saline, or may be one in which physiological saline is sucked into the syringe by a suction device (not shown).
  • the contrast medium line and the syringe 651 can be appropriately changed. That is, -Aspirate the contrast agent from the chamber 621 into the syringe 651 only once and push the contrast agent out of the syringe. -Repeat the operation of sucking and extruding the contrast agent from the chamber 621 into a reciprocating syringe (such as the syringe 550). -The connector 615C, the valve V-2, the line 605, etc.
  • the syringe may be a prefilled type in which a contrast medium is pre-filled, or may be one in which the contrast medium is sucked into the syringe by a suction device (not shown).

Abstract

In the present invention, a chemical liquid circuit (601P) is provided with a contrast agent line (605), a physiological saline line (606), a syringe line, a patient line (608) and a base line section (610). The chemical liquid circuit (601P) is further provided with first valve devices (V-1, V-2) and a second value device (V-3). (i) In a case where a liquid is suctioned toward the upstream side of the base line section (610), the first valve devices (V-1, V-2) allow the contrast agent to flow from the inside of the contrast agent line (605) to the inside of the base line section (610). (ii) In a case where the liquid is pushed toward the downstream side of the base line section (610), the first valve devices (V-1, V-2) allow the liquid to flow in the above-described direction but not in the reverse in the contrast agent line (605). The second value device (V-3) allows the liquid to flow from the physiological saline line (606) side to the base line section (610) side, but does not allow the reverse to occur.

Description

薬液回路およびそれを使用する薬液回路システムChemical circuit and chemical circuit system using the same
 本発明は、例えば造影剤や生理食塩水などの薬液を患者に注入するための薬液回路およびシステムに関し、特には、心臓カテーテル検査などの血管造影に好適に用いることができる薬液回路および薬液回路システムに関する。 The present invention relates to a chemical circuit and a system for injecting a chemical such as a contrast medium and physiological saline into a patient, and in particular, a chemical circuit and a chemical circuit system that can be suitably used for angiography such as cardiac catheter examination. About.
 医療用の画像診断装置としては、CT(Computed Tomography)スキャナ、MRI(Magnetic Resonance
Imaging)装置、PET(Positron Emission Tomography)装置、血管造影(angiography)装置、およびMRA(MR Angio)装置などがある。これらの装置を使用して患者の画像を撮像する際は、患者に造影剤や生理食塩水などの薬液を注入することが多い。
Medical diagnostic imaging devices include CT (Computed Tomography) scanners and MRI (Magnetic Resonance).
There are an imaging device, a PET (Positron Emission Tomography) device, an angiography device, and an MRA (MR Angio) device. When taking an image of a patient using these devices, a medical solution such as a contrast medium or physiological saline is often injected into the patient.
 特許文献1には、血管造影を行う際に用いられる薬液回路システムが開示されている(例えば図7A~図7B)。このシステムは、薬液回路に接続された造影剤源の薬液をシリンジ内に引き込み、それを患者に向けて注入する。 Patent Document 1 discloses a chemical circuit system used for angiography (for example, FIGS. 7A to 7B). This system draws a contrast agent source solution connected to a solution circuit into a syringe and injects it toward a patient.
特開2007-222656号公報JP 2007-222656 A
 ところで、血管造影を行う場合には、造影剤の薬液シリンジ内への吸引および患者への注入、ならびに、生理食塩水の患者への注入を所定の順番で行う必要がある(詳細後述)。このような薬液注入において、薬液のルートを変更するために、例えば三方活栓などを操作する必要がある場合、もし術者の操作ミスが発生したときには、所定の薬液を所定の手順で注入できないおそれがある。 By the way, when performing angiography, it is necessary to perform aspiration of a contrast medium into a drug solution syringe, injection into a patient, and injection of physiological saline into a patient in a predetermined order (details will be described later). In such chemical injection, if it is necessary to operate, for example, a three-way stopcock in order to change the route of the chemical, if there is an operator's operation mistake, there is a risk that the predetermined chemical cannot be injected in a predetermined procedure. There is.
 本発明は、そうした問題点に鑑みてなされたものであり、その目的は、術者による煩雑な作業を要することなく、所定の薬液を所定の手順で注入可能な薬液回路および薬液回路システムを提供することにある。 The present invention has been made in view of such problems, and an object thereof is to provide a chemical circuit and a chemical circuit system capable of injecting a predetermined chemical liquid in a predetermined procedure without requiring a complicated operation by an operator. There is to do.
 上記目的を達成するための本発明の一形態の薬液回路は下記の通りである:
 造影剤チャンバに接続される造影剤ラインと、
 生理食塩水チャンバに接続される生理食塩水ラインと、
 薬液シリンジに接続されるシリンジラインと、
 造影剤または生理食塩水を患者に向けて送るための患者ラインと、
 前記各ラインが接続されるベースライン部と、
 を備え、造影剤をいったん前記薬液シリンジ内に吸引したのち該シリンジから患者に向けて注入する薬液注入に用いられる薬液回路であって、
 さらに、
 (i)液体が前記ベースライン部の上流側に向かって引かれた場合には造影剤が造影剤ライン内から前記ベースライン部内に流れるとともに、(ii)液体が前記ベースライン部の上流側から下流側に向けて押された場合には、造影剤ライン内に逆流することなく、ベースライン部の上流側から下流側へと液体が流れることを許容する第1の弁デバイスと、
 前記生理食塩水ライン側から前記ベースライン部側への液体が流れは許容するがその逆は許容しない第2の弁デバイスと、
 を備える、薬液回路。
In order to achieve the above object, a chemical circuit according to one embodiment of the present invention is as follows:
A contrast agent line connected to the contrast agent chamber;
A saline line connected to the saline chamber;
A syringe line connected to the chemical syringe;
A patient line for delivering contrast media or saline to the patient;
A baseline part to which each line is connected;
A liquid medicine circuit that is used for liquid medicine injection for injecting a contrast medium into the liquid medicine syringe and then injecting the contrast medium from the syringe toward a patient,
further,
(I) When the liquid is drawn toward the upstream side of the baseline portion, the contrast medium flows from the contrast agent line into the baseline portion, and (ii) the liquid flows from the upstream side of the baseline portion. A first valve device that allows liquid to flow from the upstream side of the baseline portion to the downstream side without backflowing into the contrast agent line when pushed toward the downstream side;
A second valve device that allows liquid to flow from the saline line side to the baseline portion side but not vice versa;
A chemical circuit.
(用語の説明)
「接続される」とは、所定の要素が対象物に対して直接接続されるものに加え、他の何らかの要素を介した状態で接続されることも含む。
「(造影剤/生理食塩水)チャンバ」とは、ボトルやバッグなどの容器を意図し、特定の形状に限定されるものではない。
「ライン(造影剤ライン/生理食塩水ライン/シリンジライン/患者ライン等)」とは、液体の流路を意味し、必ずしも、独立したチューブ等の部材が必要であることを意味するものではない。例えば、ベースライン部に所定のコネクタが設けられており、このコネクタに対して薬液シリンジが直接接続される(チューブは用いない)ような場合には、当該コネクタの一部がシリンジラインに相当することとなる。
(Explanation of terms)
“Connected” includes not only a predetermined element directly connected to an object but also a state in which the predetermined element is connected through some other element.
The “(contrast / saline) chamber” is intended to be a container such as a bottle or a bag, and is not limited to a specific shape.
“Line (contrast line / saline line / syringe line / patient line, etc.)” means a liquid flow path, and does not necessarily mean that an independent member such as a tube is required. . For example, when a predetermined connector is provided in the baseline portion and a chemical syringe is directly connected to this connector (no tube is used), a part of the connector corresponds to the syringe line. It will be.
 本発明によれば、術者による煩雑な作業を要することなく、所定の薬液を所定の手順で注入可能な薬液回路およびシステムを提供することができる。 According to the present invention, it is possible to provide a chemical circuit and system capable of injecting a predetermined chemical liquid in a predetermined procedure without requiring a complicated operation by an operator.
本発明の一形態の薬液回路システムを模式的に示す図である。It is a figure which shows typically the chemical | medical solution circuit system of one form of this invention. デュアルチェックバルブの機能を示す模式図である。It is a schematic diagram which shows the function of a dual check valve. 薬液回路の一部を保持する切替機を模式的に示す図である。It is a figure which shows typically the switching machine holding a part of chemical | medical solution circuit. 本発明の他の形態の薬液回路システムを模式的に示す図である。It is a figure which shows typically the chemical | medical solution circuit system of the other form of this invention. 血管造影の工程の一部を示す図である(造影剤の吸引)。It is a figure which shows a part of process of angiography (contrast medium suction | inhalation). 血管造影の工程の一部を示す図である(造影剤の押出し)。It is a figure which shows a part of process of an angiography (extrusion of a contrast agent). 血管造影の工程の一部を示す図である(エアクリア)。It is a figure which shows a part of process of an angiography (air clear). 血管造影の工程の一部を示す図である(バルブの操作)。It is a figure which shows a part of process of an angiography (operation of a valve | bulb). 血管造影の工程の一部を示す図である(造影剤の押出し)。It is a figure which shows a part of process of an angiography (extrusion of a contrast agent). 血管造影の工程の一部を示す図である(生理食塩水によるフラッシュ)。It is a figure which shows a part of process of an angiography (flush with the physiological saline). 血管造影の工程の一部を示す図である(追加フラッシュ)。It is a figure which shows a part of process of an angiography (additional flash). 血管造影の工程の一部を示す図である(血液ルートの確立)。It is a figure which shows a part of process of angiography (establishment of a blood route). 本発明の他の形態の薬液回路システムを模式的に示す図である。It is a figure which shows typically the chemical | medical solution circuit system of the other form of this invention. ローラ式ポンプの一例を模式的に示す図である。It is a figure which shows an example of a roller type pump typically. ピストン式ポンプの一例を模式的に示す図である。It is a figure which shows an example of a piston type pump typically. リリースバルブの他の例を示す断面図である。It is sectional drawing which shows the other example of a release valve. 図14Aのリリースバルブの一部品を示す図面である。FIG. 14B is a drawing showing a part of the release valve of FIG. 14A. リリースバルブの一例を示す断面図である。It is sectional drawing which shows an example of a release valve. 本発明の他の一形態の薬液回路および薬液回路システム模式的に示す図である。It is a figure which shows typically the chemical | medical solution circuit and chemical | medical solution circuit system of other one form of this invention. 塵埃防止型シリンジの一例を模式的に示す断面図である。It is sectional drawing which shows typically an example of a dust prevention type syringe. 第2ピストンを背面側から見た模式図である。It is the schematic diagram which looked at the 2nd piston from the back side. 本発明のさらに他の一形態の薬液回路および薬液回路システム模式的に示す図である。It is a figure which shows typically the chemical | medical solution circuit and chemical | medical solution circuit system of another one form of this invention. クランピング機構の構成例を模式的に示す図である。It is a figure which shows typically the structural example of a clamping mechanism. 図20Aのクランピング機構の構成例の変形例の1つを模式的に示す図である。It is a figure which shows typically one of the modifications of the structural example of the clamping mechanism of FIG. 20A. クランピング機構の他の構成例を模式的に示す図である。It is a figure which shows typically the other structural example of a clamping mechanism. クランピング機構の別の構成例を模式的に示す図である。It is a figure which shows typically another structural example of a clamping mechanism. クランピング機構のさらに別の構成例を模式的に示す図である。It is a figure which shows typically another structural example of a clamping mechanism.
 以下、図面を参照して本発明の一形態について説明する。なお、以下の説明では上、下、右、左などの方向を示す用語を用いるが、これは本発明を何ら限定するものではない。また、造影剤と生理食塩水を区別することなく単に「薬液」または「液体」と称するこことがある。 Hereinafter, an embodiment of the present invention will be described with reference to the drawings. In the following description, terms indicating directions such as up, down, right, and left are used, but this does not limit the present invention. Further, the contrast agent and the physiological saline may be simply referred to as “medical solution” or “liquid” without being distinguished.
(第1の実施形態)
 図1に示す本実施形態の薬液回路システム200は、例えば、心臓カテーテル検査に利用されるものである。この薬液回路システム200は、薬液回路201(詳細下記)と、それに接続される造影剤チャンバ221、生理食塩水チャンバ223、圧力トランスデューサ270、および薬液シリンジ251を備えている。薬液回路システム200は、また、シリンジ251を保持して薬液の吸引・押出しを行う注入ヘッド260(一部のみを図示する、インジェクタとも言う)も備えている。
(First embodiment)
A chemical circuit system 200 according to this embodiment shown in FIG. 1 is used for, for example, cardiac catheter examination. The chemical circuit system 200 includes a chemical circuit 201 (detailed below), a contrast medium chamber 221, a physiological saline chamber 223, a pressure transducer 270, and a chemical syringe 251 connected thereto. The chemical circuit system 200 also includes an injection head 260 that holds the syringe 251 and sucks and pushes out the chemical (only a part of the injection circuit 260 is also illustrated).
 図1の薬液回路201は、具体的には、シリンジ251に接続されるシリンジライン204と、造影剤チャンバ221に接続される造影剤ライン205と、生理食塩水チャンバ223に接続される生理食塩水ライン206と、トランスデューサ270に接続されるトランスデューサライン207と、カテーテル(不図示)を介して患者に接続される患者ライン208と、それら各ラインが接続されるベースライン部210と、を備えている。 Specifically, the drug solution circuit 201 of FIG. 1 includes a syringe line 204 connected to the syringe 251, a contrast agent line 205 connected to the contrast agent chamber 221, and physiological saline connected to the physiological saline chamber 223. A line 206, a transducer line 207 connected to the transducer 270, a patient line 208 connected to the patient via a catheter (not shown), and a baseline portion 210 to which these lines are connected. .
 各ライン204~208を構成するチューブの材質や、長さおよび径については、そのチューブに加わる圧力等を考慮して適宜選択すればよい。心臓カテーテル検査においては、比較的高圧で薬液が注入されることとなるため、高い圧力がかかる部分に関しては、高耐圧のチューブで構成されていることが好ましい。同様に、後述するデュアルチェックバルブ215A、215Bおよびリリースバルブ202A、202B等も高耐圧のものであることが好ましい。 The material, length, and diameter of the tubes constituting the lines 204 to 208 may be appropriately selected in consideration of the pressure applied to the tubes. In a cardiac catheter test, since a chemical solution is injected at a relatively high pressure, a portion to which a high pressure is applied is preferably composed of a high pressure resistant tube. Similarly, dual check valves 215A and 215B and release valves 202A and 202B, which will be described later, preferably have a high breakdown voltage.
 「ベースライン部210」とは、図1に示すように、上記各ライン204~208が接続される部分のことを指し、チューブ、バルブおよびコネクタ等で構成されている。この例では、ベースライン部210の上流側にシリンジライン204が接続されるとともに、下流側に患者ライン208が接続されている。ベースライン部210の中間部には、上流側から順に、造影剤ライン205、生理食塩水ライン206、およびトランスデューサライン207が接続される。これらのライン205~207はそれぞれ、ベースライン部210に対してT字状に接続されている。 The “baseline part 210” refers to a part to which the above-mentioned lines 204 to 208 are connected as shown in FIG. 1, and is composed of tubes, valves, connectors and the like. In this example, the syringe line 204 is connected to the upstream side of the baseline part 210 and the patient line 208 is connected to the downstream side. A contrast medium line 205, a physiological saline line 206, and a transducer line 207 are connected to an intermediate portion of the base line portion 210 sequentially from the upstream side. Each of these lines 205 to 207 is connected to the base line portion 210 in a T shape.
 なお、「T字状に接続」とは、流路が分岐するように接続されることを意図しており、ラインが交差する角度を何ら限定するものではない。 Note that “connected in a T-shape” is intended to connect so that the flow path branches, and does not limit the angle at which the lines intersect.
 本実施形態では、造影剤ライン205および生理食塩水ライン206は、それぞれ、デュアルチェックバルブ215A、215Bによってベースライン部210に接続されている。2つのデュアルチェックバルブ215A、B(詳細下記)は、一例として、同一のものを利用してもよいし、または、機能が異なる別々のものを利用してもよい。図1では、一例として、同一のものが利用されている。 In this embodiment, the contrast medium line 205 and the physiological saline line 206 are connected to the base line unit 210 by dual check valves 215A and 215B, respectively. As an example, the two dual check valves 215A, B (detailed below) may be the same, or different ones having different functions may be used. In FIG. 1, the same thing is utilized as an example.
 デュアルチェックバルブ215A、215Bは、下記のような機能を有する弁である(図2Aも参照):
(i)液体がベースライン部210の上流側(すなわち、シリンジ251側)に向かって引かれた場合には、液体がその方向に流れるのを許容する。
(ii)一方、デュアルチェックバルブ215Aに関しては、液体がベースライン部210の上流側から下流側に向けて押された場合には、該バルブ215Aを通過して下流側へと液体が流れる。デュアルチェックバルブ215Bに関しては、同様に液体が下流側に向けて押された場合、もしくは、生理食塩水ライン206側から該バルブ215B側に向けて押された場合に、それらの方向に液体が流れる。
The dual check valves 215A and 215B are valves having the following functions (see also FIG. 2A):
(I) When the liquid is drawn toward the upstream side of the baseline portion 210 (that is, the syringe 251 side), the liquid is allowed to flow in that direction.
(Ii) On the other hand, regarding the dual check valve 215A, when the liquid is pushed from the upstream side to the downstream side of the baseline part 210, the liquid flows through the valve 215A to the downstream side. As for the dual check valve 215B, when the liquid is similarly pushed toward the downstream side or when being pushed from the physiological saline line 206 side toward the valve 215B side, the liquid flows in those directions. .
 また、デュアルチェックバルブ215A、215Bは、図2Aに示すように、下流側から上流側への流れ、およびライン205、206側に向う流れを制限する。 Also, the dual check valves 215A and 215B restrict the flow from the downstream side to the upstream side and the flow toward the lines 205 and 206 as shown in FIG. 2A.
 なお、図1では、デュアルチェックバルブ215Bの上流にもう1つのバルブ215Aが配置されておりこのバルブ215Aによって液体の上流側への流れは制限されているため、この回路では、生理食塩水が上流側に向かって引かれることはない。 In FIG. 1, another valve 215A is arranged upstream of the dual check valve 215B, and the flow of the liquid upstream is restricted by this valve 215A. It is not pulled toward the side.
 トランスデューサライン207は、図1に示すように、一例として弁機能の無いT字コネクタ217によってベースライン部210に接続されている。このT字コネクタ217とデュアルチェックバルブ215Bとの間には三方活栓213が設けられていてもよい。ただし、この三方活栓213の配置位置は必ずしもこれに限定されるものではない。図2Cに示すように、活栓213を、患者ライン208のエアセンサ232(詳細下記)より下流に配置してもよい。 As shown in FIG. 1, the transducer line 207 is connected to the base line part 210 by a T-shaped connector 217 having no valve function as an example. A three-way cock 213 may be provided between the T-shaped connector 217 and the dual check valve 215B. However, the arrangement position of the three-way cock 213 is not necessarily limited to this. As shown in FIG. 2C, the stopcock 213 may be disposed downstream of the air sensor 232 (detailed below) in the patient line 208.
 三方活栓213は、一例として、そこに接続される3つのラインのうちレバーの方向に沿う1つが閉塞されるもの(例えば、図1の状態では、下向きに延びる不図示のラインへの液体の移動が阻止される)であってもよい。このような三方活栓は、術者がライン中の液体を、必要に応じて、外部に排出する場合などに用いられる。 As an example, the three-way stopcock 213 is one in which one of the three lines connected thereto is closed along the direction of the lever (for example, in the state of FIG. 1, the liquid moves to a line (not shown) that extends downward) May be prevented). Such a three-way cock is used when an operator discharges the liquid in the line to the outside as needed.
 次に、各ライン204~208に接続される機器等について説明する。なお、これらの機器は従来公知のものを利用可能であるため、詳細な説明は省略するものとする。 Next, the devices connected to the lines 204 to 208 will be described. In addition, since these apparatuses can use a conventionally well-known apparatus, detailed description shall be abbreviate | omitted.
 シリンジライン204が接続される薬液シリンジ251としては、例えばその容量が数十ml~200ml程度のものであってもよい。また、シリンジ251としては、心臓カテーテル検査等を行う場合には、高圧注入を実施できるものであることが好ましい。必要に応じて、シリンジ251を覆う保護カバーが用いられてもよい。シリンジ251は、筒状のシリンダ部材と、そのシリンダ部材内にスライド自在に挿入されたピストン部材(プランジャロッド)とを有している。なお、ピストン部材はいわゆるロッドレスタイプのものであってもよい。 The chemical syringe 251 to which the syringe line 204 is connected may have a capacity of, for example, about several tens to 200 ml. Moreover, it is preferable that the syringe 251 can perform high-pressure injection when performing a cardiac catheter test or the like. If necessary, a protective cover that covers the syringe 251 may be used. The syringe 251 has a cylindrical cylinder member and a piston member (plunger rod) that is slidably inserted into the cylinder member. The piston member may be a so-called rodless type.
 薬液シリンジ251が取外し可能に装着されるインジェクタ(注入ヘッド)260は、限定されるものではないが、例えば高圧注入を行うことができるタイプであることが望ましい。インジェクタ260は、駆動源であるモータと、前後に移動するプレッサー部材とを有している。プレッサー部材を引くことで、シリンジのピストン部材が引かれてシリンジ内に薬液が充填される、一方、プレッサー部材を押すことで、シリンジ内の液体が外部に押し出される。 The injector (injection head) 260 to which the chemical syringe 251 is detachably mounted is not limited, but is preferably a type that can perform high-pressure injection, for example. The injector 260 includes a motor that is a driving source and a presser member that moves back and forth. By pulling the presser member, the piston member of the syringe is pulled to fill the syringe with the chemical solution, while by pressing the presser member, the liquid in the syringe is pushed out.
 インジェクタ260としては、一本のシリンジのみが搭載される一筒式のものであってもよいし、二本のシリンジのみが搭載される二筒式のもの等であってもよい。また、CT検査用のインジェクタ、MR検査用のインジェクタ、アンギオグラフィ検査用のインジェクタ等を利用してもよい。 The injector 260 may be a one-cylinder type in which only one syringe is mounted, or a two-cylinder type in which only two syringes are mounted. Further, an injector for CT inspection, an injector for MR inspection, an injector for angiography inspection, and the like may be used.
(薬液注入装置)
 なお、詳細な図示は省略するが、インジェクタ(注入ヘッド)260にコンソール(制御ユニット)が接続され薬液注入装置が構成されてもよい。コンソールは、有線または無線方式でインジェクタ260と接続可能である。コンソールは、1つまたは複数のディスプレイと、マイクロプロセッサ等を含んだ制御ユニット(コントロールユニット、コントローラ)とを有していてもよい。このディスプレイは、一例でタッチパネル式であってもよい。このように「インジェクタ(注入ヘッド)」という用語と「コンソール」という用語とを使い分けた場合においても、本発明においては、これらが一体的に構成されること、例えばコンソールとインジェクタとが1つの筐体内に設けられることが妨げられるものではない。
(Chemical injection device)
In addition, although detailed illustration is abbreviate | omitted, a console (control unit) may be connected to the injector (injection head) 260, and a chemical | medical solution injection apparatus may be comprised. The console can be connected to the injector 260 in a wired or wireless manner. The console may have one or a plurality of displays and a control unit (control unit, controller) including a microprocessor or the like. This display may be a touch panel type as an example. Thus, even when the term “injector (injection head)” and the term “console” are properly used, in the present invention, these are configured integrally, for example, the console and the injector are in one housing. It is not impeded to be provided in the body.
(ピストン駆動機構の一例)
 ピストン駆動機構は、モータ等の駆動源(不図示)からの動力を受けて、その場で正逆回転するシャフトを有するものであってもよい。このシャフトを所定数回転させると、それに応じた距離だけ、プレッサー部材(ラム部材)が前後方向に移動する。ラム部材の押圧面には、ピストンに加えられる押圧力を検出するためのロードセル(圧力センサ)が取り付けられていてもよい。なお、モータ電流の値に基いて押圧力を検出する方式とすることもできる。
(Example of piston drive mechanism)
The piston drive mechanism may have a shaft that receives power from a drive source (not shown) such as a motor and rotates forward and backward on the spot. When this shaft is rotated a predetermined number of times, the presser member (ram member) moves in the front-rear direction by a distance corresponding thereto. A load cell (pressure sensor) for detecting a pressing force applied to the piston may be attached to the pressing surface of the ram member. A method of detecting the pressing force based on the value of the motor current can also be adopted.
(シリンジ)
 シリンジとしては種々のものを利用可能であるが、例えば、シリンジ外筒(シリンダ部材)は、例えばポリエチレン、ポリプロピレンのような樹脂材料よりなるものであってもよいし、ガラス製のものであってもよい。シリンジ外筒の少なくとも薬液が収納される部分は、内部の薬液の残量を視認し得るように、透光性を有するもの、すなわち透明または半透明であるのが好ましい。そして、シリンジ外筒の外周面には、薬液の残量を表示し得る目盛り(図示せず)が付されているのが好ましい。シリンジのガスケット(ピストン部材の先端部分)は、シリンジ外筒内で軸方向に液密に摺動するものであり、その少なくとも外周部が弾性のシール部材で構成されていてもよい。
(Syringe)
Various syringes can be used. For example, the syringe outer cylinder (cylinder member) may be made of a resin material such as polyethylene or polypropylene, or made of glass. Also good. It is preferable that at least a portion of the syringe outer cylinder in which the chemical solution is stored has a light-transmitting property, that is, is transparent or translucent so that the remaining amount of the chemical solution inside can be visually recognized. And it is preferable to attach the scale (not shown) which can display the residual amount of a chemical | medical solution to the outer peripheral surface of a syringe outer cylinder. The gasket of the syringe (the tip portion of the piston member) slides in a liquid-tight manner in the axial direction within the syringe outer cylinder, and at least the outer peripheral portion thereof may be formed of an elastic seal member.
 再び回路の説明に戻る。造影剤ライン205が接続される造影剤チャンバ221は、一例として造影剤が充填されたボトル状の容器であってもよい。造影剤チャンバ221は、不図示の吊り具に吊り下げられて使用されるものであってもよく、この造影剤チャンバ221の下部に造影剤ライン205が接続される。この接続は、ニードルを介して行われるものであってもよい。 Return to the explanation of the circuit. As an example, the contrast agent chamber 221 to which the contrast agent line 205 is connected may be a bottle-like container filled with a contrast agent. The contrast agent chamber 221 may be used while being suspended by a suspender (not shown), and the contrast agent line 205 is connected to the lower portion of the contrast agent chamber 221. This connection may be made via a needle.
 図1に示すように、造影剤チャンバ221の下方には、造影剤ライン205内の液体に空気が混入しているか否かを検出するためのエアセンサ231(例えば赤外線センサ)が配置されている。このエアセンサ231でライン内の空気を検知することにより、チャンバ内の薬液が無くなったことを検出することができる。エアセンサ231の下方であって、造影剤ライン205上には点滴用チャンバ233が配置されており、造影剤チャンバ221からの造影剤は一旦このチャンバ233内に滴下し、このチャンバ233内から造影剤ライン205内へと流れるようになっている。 As shown in FIG. 1, an air sensor 231 (for example, an infrared sensor) for detecting whether air is mixed in the liquid in the contrast medium line 205 is disposed below the contrast medium chamber 221. By detecting the air in the line by the air sensor 231, it can be detected that the chemical liquid in the chamber has run out. A drip chamber 233 is disposed below the air sensor 231 and on the contrast medium line 205, and the contrast medium from the contrast medium chamber 221 once drops into the chamber 233, and the contrast medium from within the chamber 233. It flows into the line 205.
 生理食塩水ライン206が接続される生理食塩水チャンバ223は、一例として生理食塩水が充填されたバッグ状の容器であってもよく、この例ではさらに、バッグを加圧するための加圧手段224を備えている(このような構成のものを「加圧バッグ」ともいう)。加圧バッグは市販のものを利用してもよい。加圧手段224は、限定されるものではないが、空気などの流体を駆動源としてバッグを圧縮するものであってもよいし、または、モータ等を駆動源としてバッグを圧縮するものであってもよい。造影剤ライン205と同様、生理食塩水ライン206にも同様のエアセンサ231および点滴用チャンバ233が配置されている。なお、生理食塩水を加圧するための機構は上記に限定されるものでないが、他の構成については後述するものとする。 As an example, the physiological saline chamber 223 to which the physiological saline line 206 is connected may be a bag-like container filled with physiological saline, and in this example, further, a pressurizing means 224 for pressurizing the bag. (This type of structure is also referred to as a “pressure bag”). Commercially available pressure bags may be used. The pressurizing means 224 is not limited, and may compress the bag using a fluid such as air as a driving source, or compress the bag using a motor or the like as a driving source. Also good. Similar to the contrast agent line 205, a similar air sensor 231 and drip chamber 233 are also disposed in the physiological saline line 206. The mechanism for pressurizing the physiological saline is not limited to the above, but other configurations will be described later.
 生理食塩水ライン206には、そのライン206の開閉を切り替えるためのリリースバルブ202Aが設けられている。リリースバルブ202Aは、外力を受けて移動する可動部材203を有し、その可動部材203を移動させることによって開弁/閉弁状態が切り替わり生理食塩水ライン206を開閉する。本実施形態では一例として、可動部材203を押すことによりバルブ202Aが開き、加圧バッグからの生理食塩水がベースライン部210側へと流れる(液体が流れる方向は液体の圧力差に依存する)ように構成されている。 The physiological saline line 206 is provided with a release valve 202A for switching opening and closing of the line 206. The release valve 202A has a movable member 203 that moves in response to an external force. By moving the movable member 203, the valve opening / closing state is switched to open and close the physiological saline line 206. In this embodiment, as an example, the valve 202A is opened by pushing the movable member 203, and physiological saline from the pressurized bag flows toward the baseline portion 210 (the direction in which the liquid flows depends on the pressure difference of the liquid). It is configured as follows.
 次に、トランスデューサライン207に接続される機器等について説明する。このライン207に接続される圧力トランスデューサ270は、一例として、血圧を検出して患者の脈をモニタリングできるようにするものである。一例として、脈の波形はトランデューサ270に接続されたディスプレイ271に表示されるように構成されている。 Next, devices and the like connected to the transducer line 207 will be described. For example, the pressure transducer 270 connected to the line 207 detects blood pressure so that the patient's pulse can be monitored. As an example, the pulse waveform is configured to be displayed on a display 271 connected to the transducer 270.
 トランスデューサライン207にも、生理食塩水ライン206のリリースバルブ202Aと同様のリリースバルブ202Bが設けられている。ただし、その向きはリリースバルブ202Aとは逆向きである。このリリースバルブ202Bでは、可動部材203を押すことにより、薬液がトランスデューサ270側に流れることができる状態となる。 The transducer valve 207 is also provided with a release valve 202B similar to the release valve 202A of the physiological saline line 206. However, the direction is opposite to that of the release valve 202A. In this release valve 202B, the movable member 203 is pushed, so that the chemical liquid can flow to the transducer 270 side.
 なお、図1の例では、一方のリリースバルブ202Aの可動部材203と他方のリリースバルブ202Bの可動部材203とが互いに向かい合った配置となっている。さらに、後述する切替機300の構成に対応するように、ベースライン部210から各バルブの可動部材203、203までの距離(L1、L2)が同一とならないように配置されている。 In the example of FIG. 1, the movable member 203 of one release valve 202A and the movable member 203 of the other release valve 202B are arranged to face each other. Furthermore, the distance (L1, L2) from the base line part 210 to the movable members 203, 203 of each valve is arranged so as not to be the same so as to correspond to the configuration of the switching machine 300 described later.
 患者ライン208の先端部にはカテーテル(不図示)とよばれる細い管が接続され、このカテーテルは患者の血管内に挿入される。心臓カテーテル検査においては、カテーテル先端は例えば冠動脈などにまで移送され、このカテーテル先端から造影剤等が血管内へ注入される。 A thin tube called a catheter (not shown) is connected to the distal end of the patient line 208, and this catheter is inserted into the patient's blood vessel. In the cardiac catheter test, the catheter tip is transferred to, for example, the coronary artery, and a contrast agent or the like is injected into the blood vessel from the catheter tip.
 続いて、図2Bを参照して、図1の薬液回路201の一部を保持してその流れを適宜切り替えるための切替機300について説明する。この切替機300は、一例として箱状のハウジング310を備える。切替機300は、生理食塩水ライン206の一部を保持するための第1の保持部306と、トランスデューサライン207の一部を保持するための第2の保持部307とを有している。これらの保持部306、307は凹状に形成され、その内部に各ラインのリリースバルブ202A、202Bがセットされるように構成されている。 Subsequently, with reference to FIG. 2B, a switching device 300 for holding a part of the chemical circuit 201 of FIG. 1 and switching the flow thereof as appropriate will be described. The switching machine 300 includes a box-shaped housing 310 as an example. The switching device 300 includes a first holding unit 306 for holding a part of the physiological saline line 206 and a second holding unit 307 for holding a part of the transducer line 207. These holding portions 306 and 307 are formed in a concave shape, and the release valves 202A and 202B of each line are set therein.
 切替機300のハウジング310内部には、例えばモータを駆動源として電気機械的に各バルブ202A、202Bの可動部材203、203を押す駆動部301、301が設けられている。この駆動部301、301は、外部のコントローラ350からの制御信号に応じて動作するように構成されていてもよい。このコントローラ350の機能は、特に限定されるものではないが、インジェクタ260が有していてもよい。 In the housing 310 of the switching machine 300, for example, driving units 301 and 301 that push the movable members 203 and 203 of the valves 202A and 202B electromechanically using, for example, a motor as a driving source are provided. The driving units 301 and 301 may be configured to operate in response to a control signal from an external controller 350. The function of the controller 350 is not particularly limited, but the injector 260 may have the function.
 切替機300はまた、患者ライン208の一部を保持する第3の保持部308およびその患者ライン208内の気泡の有無を検出するためのエアセンサ332を有している。このエアセンサ332は、一例として超音波式のものであってもよい。超音波式のセンサ332は、赤外線式のもの等に比べて、高圧条件下で液体に気泡が混入した場合であってもそれらを良好に見つけることができる点で有利である。 The switching machine 300 also includes a third holding unit 308 that holds a part of the patient line 208 and an air sensor 332 that detects the presence or absence of bubbles in the patient line 208. For example, the air sensor 332 may be an ultrasonic sensor. The ultrasonic sensor 332 is advantageous in that, even when bubbles are mixed in the liquid under a high pressure condition, the ultrasonic sensor 332 can be found well.
 上記のように構成された本実施形態の薬液回路200の使用方法について、以下、説明する。 Hereinafter, a method for using the chemical circuit 200 of the present embodiment configured as described above will be described.
 図3は初期状態を示しており、この状態では、リリースバルブ202A、202Bの可動部材203、203は押されておらず液体が双方向には流れない状態となっている。図3の状態で、インジェクタ206の所定のボタン(エアクリア用ボタン)を術者が押すと、そのピストン駆動機構が動作してシリンジ251のピストン部材を引く。これにより、シリンジ251およびシリンジライン204内が負圧となり、造影剤ライン205およびデュアルチェックバルブ215Aを経由して、チャンバ221内の造影剤がシリンジライン205、204およびシリンジ251内に引き込まれる。 FIG. 3 shows an initial state. In this state, the movable members 203 and 203 of the release valves 202A and 202B are not pushed and the liquid does not flow bidirectionally. In the state of FIG. 3, when the operator presses a predetermined button (air clear button) of the injector 206, the piston drive mechanism operates to pull the piston member of the syringe 251. Thereby, the inside of the syringe 251 and the syringe line 204 becomes negative pressure, and the contrast agent in the chamber 221 is drawn into the syringe lines 205 and 204 and the syringe 251 via the contrast agent line 205 and the dual check valve 215A.
 次いで、図4に示すように、今度はシリンジ251のピストン部材を押し、シリンジ251内から造影剤を押し出す。液体は、シリンジライン204を通ってベースライン部210側へと送られ、2つのデュアルチェックバルブ215A、215Bを通過してベースライン部210を満たしていく。この造影剤の押出し動作は、図4に示すように、造影剤が少なくともデュアルチェックバルブ215Bを超える程度に押し出されるまで、続けられる。 Next, as shown in FIG. 4, this time, the piston member of the syringe 251 is pushed, and the contrast agent is pushed out from the syringe 251. The liquid passes through the syringe line 204 to the baseline part 210 side, passes through the two dual check valves 215A and 215B, and fills the baseline part 210. This extrusion operation of the contrast agent is continued until the contrast agent is pushed out at least beyond the dual check valve 215B, as shown in FIG.
 次いで、図5に示すように、リリースバルブ202Aの可動部材203およびリリースバルブ202Bの可動部材203を押し、両バルブ202A、202Bを開放する。この開放は、切替機300の駆動部301、301が各可動部材を押すことによって自動で行われる。この時点では、生理食塩水チャンバ223の加圧手段224が駆動され、生理食塩水に所定の圧力(例えば300mmHg程度)が加わった状態となっている。したがって、バルブ202Aの開放により、生理食塩水はチャンバ223側からベースライン部210に向かって流れ、リリースバルブ202Aおよびデュアルチェックバルブ215Bを通過して、患者ライン208側へと流れる。造影剤はさらに、三方活栓213を通過するとともにコネクタ217のところで分岐して、一部は患者ライン208内へと流れ、他の一部はトランスデューサライン207内へと流れ込む。ここで、リリースバルブ202Bは開放されているので、生理食塩水は、リリースバルブ202Bを超えてトランスデューサ270に向かって流れる。このように各ラインを生理食塩水で満たすことによりライン中の気泡が外部へと除去される。 Next, as shown in FIG. 5, the movable member 203 of the release valve 202A and the movable member 203 of the release valve 202B are pushed to open both valves 202A and 202B. The opening is automatically performed when the driving units 301 and 301 of the switching machine 300 press each movable member. At this time, the pressurizing means 224 of the physiological saline chamber 223 is driven, and a predetermined pressure (for example, about 300 mmHg) is applied to the physiological saline. Therefore, when the valve 202A is opened, the physiological saline flows from the chamber 223 side toward the base line part 210, passes through the release valve 202A and the dual check valve 215B, and flows toward the patient line 208 side. The contrast agent further passes through the three-way stopcock 213 and branches at the connector 217, with some flowing into the patient line 208 and the other flowing into the transducer line 207. Here, since the release valve 202B is opened, the physiological saline flows toward the transducer 270 beyond the release valve 202B. In this way, by filling each line with physiological saline, bubbles in the line are removed to the outside.
 次いで、図6の示すように、生理食塩水ライン206のリリースバルブ202Aの可動部材203を押圧するのを解除し、生理食塩水がリリースバルブ202Aを超えて下流側に流れない状態とする。また、次の造影剤注入工程で造影剤がトランデューサ270側に流れ込まないように、トランスデューサライン207のリリースバルブ202Bの可動部材203ついても押圧を解除し、造影剤等がリリースバルブ202Bを超えてトランスデューサ側に流れない状態とする。 Next, as shown in FIG. 6, the pressing of the movable member 203 of the release valve 202A of the physiological saline line 206 is released so that the physiological saline does not flow downstream beyond the release valve 202A. In addition, the pressing of the movable member 203 of the release valve 202B of the transducer line 207 is released so that the contrast agent does not flow into the transducer 270 side in the next contrast agent injection step, and the contrast agent or the like exceeds the release valve 202B. Make sure that it does not flow to the transducer side.
 次いで、インジェクタ206のピストン駆動機構を動作させてシリンジ251のピストン部材を押すことで、図7に示すようにシリンジ251内の造影剤を患者に向けて押し出す。具体的には、造影剤は、造影剤ライン204、ベースライン部210、患者ライン208、および不図示のカテーテルを通って、患者体内の所定の撮像部位(一例として、心臓の冠動脈など)へと送られる。 Next, by operating the piston drive mechanism of the injector 206 and pushing the piston member of the syringe 251, the contrast medium in the syringe 251 is pushed out toward the patient as shown in FIG. Specifically, the contrast agent passes through the contrast agent line 204, the baseline portion 210, the patient line 208, and a catheter (not shown) to a predetermined imaging site (for example, a coronary artery of the heart) in the patient body. Sent.
 次いで、造影剤を注入し終わり回路内の残圧が十分に低下した後、図8に示すように生理食塩水ライン206のリリースバルブ202Aの可動部材203を押して、バルブを再び開放する。前述した工程と同様、この時点では、加圧バッグの加圧手段224によって生理食塩水に所定の圧力(例えば300mmHg程度)が加わった状態となっているので、図8に示すように生理食塩水は、ベースライン部210および患者ライン208へと送り出され、造影剤のフラッシュが行われる。 Next, after the contrast agent is injected and the residual pressure in the circuit is sufficiently lowered, the movable member 203 of the release valve 202A of the physiological saline line 206 is pushed as shown in FIG. 8 to open the valve again. Similar to the process described above, at this time, a predetermined pressure (for example, about 300 mmHg) is applied to the physiological saline by the pressurizing means 224 of the pressure bag. Is sent to the base line part 210 and the patient line 208, and the contrast medium is flushed.
 次いで、必要に応じてさらに図9に示すように、トランスデューサライン207のリリースバルブ202Bを開放し、これにより、リリースバルブ202Bよりもトランスデューサ側にも生理食塩水を流し、この領域についても生理食塩水によるフラッシュを行う。 Next, as shown in FIG. 9, if necessary, the release valve 202B of the transducer line 207 is opened, whereby physiological saline is caused to flow further to the transducer side than the release valve 202B. Do a flash by.
 その後、図10に示すように、生理食塩水ライン206のチェックバルブ202Aの可動部材203の押圧を解除し、生理食塩水がバルブ202Aを超えてベースライン部210側に流れない状態とする。これにより、ベースライン部210よりも下流側の生理食塩水の加圧状態が解除される。その結果、図10に示すように、患者ライン208とトランスデューサライン207とを通じて血液ルートが確立され、トランスデューサ270によって血圧を検出できる状態となる。 Thereafter, as shown in FIG. 10, the pressing of the movable member 203 of the check valve 202A of the physiological saline line 206 is released, and the physiological saline does not flow to the base line part 210 side beyond the valve 202A. Thereby, the pressurized state of the physiological saline downstream of the baseline part 210 is released. As a result, as shown in FIG. 10, a blood route is established through the patient line 208 and the transducer line 207, and the blood pressure can be detected by the transducer 270.
 以上説明したように、本実施形態の薬液回路201は、造影剤ライン205、生理食塩水ライン206、シリンジライン204、患者ライン208、およびベースライン部210を備えており、かつ、造影剤ライン205とベースライン部210との接続部および生理食塩水ライン206とベースライン部206との接続部には液体の流れを所定方向に規制するデュアルチェックバルブ215A、215Bが設けられている。したがって、術者が三方活栓を手で切り替えたりする作業を要することなく、シリンジ251内への造影剤の吸引(図3)およびそれに続く造影剤の送出(図4)などを良好に実施することができる。 As described above, the chemical circuit 201 according to the present embodiment includes the contrast medium line 205, the physiological saline line 206, the syringe line 204, the patient line 208, and the base line section 210, and the contrast medium line 205. Dual check valves 215A and 215B for restricting the flow of the liquid in a predetermined direction are provided at a connection portion between the base line portion 210 and the physiological saline line 206 and the base line portion 206. Therefore, it is possible to satisfactorily perform the suction of the contrast medium into the syringe 251 (FIG. 3) and the subsequent delivery of the contrast medium (FIG. 4) without requiring the operator to manually switch the three-way stopcock. Can do.
 また、本実施形態の薬液回路201は、生理食塩水ライン206にリリースバルブ202Aが設けられている。特に、このリリースバルブ202Aは、可動部材203を押すことで開閉を切り替えるものであるので、例えば三方活栓のようなレバーをひねることで開閉を切り替えるタイプと比較して切替動作を行い易い。具体的には、モータ等のアクチュエータを利用した、切替機による自動的な切替を行い易いという利点がある。さらに、このような可動部材203の移動は、レバーをひねる場合と比較して短時間で実施可能である。また、本実施形態のようにリリースバルブ202A、202B自体の機能によって流路を閉塞する構成の場合、例えばチューブをつぶして閉塞するものと比べてより確実に閉塞を行うことができる。 Also, the chemical circuit 201 of this embodiment is provided with a release valve 202A in the physiological saline line 206. In particular, since the release valve 202A switches between opening and closing by pressing the movable member 203, for example, the release valve 202A can be easily switched compared to a type in which opening and closing is switched by twisting a lever such as a three-way cock. Specifically, there is an advantage that it is easy to perform automatic switching by a switching machine using an actuator such as a motor. Further, such movement of the movable member 203 can be performed in a short time compared to the case of twisting the lever. Further, in the case of the configuration in which the flow path is closed by the function of the release valves 202A and 202B itself as in the present embodiment, for example, the closing can be performed more reliably than when the tube is crushed and closed.
 さらに、本実施形態の構成では、リリースバルブ202Bを用いてトランスデューサライン207を良好に閉塞することができるため、心臓カテーテル検査といった高圧の注入を行う場合であっても、高圧の液体のトランデューサ270側への流入を防止でき、ひいてはトランスデューサ270の破損、損傷を未然に防ぐことができる。 Furthermore, in the configuration of the present embodiment, the transducer line 207 can be satisfactorily closed using the release valve 202B, so that a high-pressure liquid transducer 270 can be used even when a high-pressure injection such as a cardiac catheter test is performed. Inflow to the side can be prevented, and as a result, breakage and damage of the transducer 270 can be prevented.
 本実施形態の薬液回路201は、一例として、造影剤ライン205、生理食塩水ライン206、シリンジライン204、トランスデューサライン207、患者ライン208、およびベースライン部210を1つのセットとして、ディスポーザブルとして用いられるものであってもよい。すなわち、薬液回路201は複数回使用することも可能であるが、感染症などの防止を目的として、一人の患者に対する使用が終った時点で新しいものに交換されてもよい。この場合、生理食塩水ライン206および造影剤ライン205の点滴用チャンバ233、233(一方のみでも可)も含めて、ディスポーザブルとしてもよい。 As an example, the drug solution circuit 201 of the present embodiment is used as a disposable with the contrast medium line 205, the physiological saline line 206, the syringe line 204, the transducer line 207, the patient line 208, and the base line unit 210 as one set. It may be a thing. That is, the chemical circuit 201 can be used a plurality of times, but may be replaced with a new one when the use with respect to one patient is completed for the purpose of preventing infection. In this case, it may be disposable including the drip chambers 233 and 233 (only one of them) of the physiological saline line 206 and the contrast medium line 205.
 また、本実施形態の薬液回路システムは、上記薬液回路201を利用するものであり、シリンジ251を搭載して液体の吸引および注入(送出)を行うインジェクタと、薬液回路201の所定のラインの開閉を自動で切り替える切替機300とを備えている。このようなシステムによれば、術者が三方活栓を切り替えたりする作業を要することなく、造影剤および生理食塩水の一連の注入動作を適切に行うことができ、必要に応じて、全ての工程を自動で行うことも可能となる。 In addition, the chemical circuit system of the present embodiment uses the chemical circuit 201 described above, and includes an injector that mounts the syringe 251 and performs suction and injection (delivery) of liquid, and opening and closing a predetermined line of the chemical circuit 201. And a switching device 300 that automatically switches between. According to such a system, it is possible to appropriately perform a series of injection operations of contrast medium and physiological saline without requiring the operator to switch the three-way stopcock, and if necessary, all steps Can also be performed automatically.
 本発明は上記に説明した形態に限定されるものでない。例えば、生理食塩水を押し出す構成として、加圧バッグの代わりに、チューブを連続的に押しつぶしてチューブ内の生理食塩水を所定方向に流すチューブポンプを利用してもよい。または、小型のシリンジのピストン部材を往復移動させることで生理食塩水の吸引と押出しを繰り返す装置を用いることもでき、この装置は、カム機構および付勢部材(例えばバネ)を利用するものであってもよい。 The present invention is not limited to the form described above. For example, as a configuration for extruding physiological saline, a tube pump that continuously crushes the tube and flows physiological saline in the tube in a predetermined direction may be used instead of the pressure bag. Alternatively, a device that repeatedly sucks and pushes physiological saline by reciprocating the piston member of a small syringe can be used. This device uses a cam mechanism and a biasing member (for example, a spring). May be.
(第2の実施形態-1-)
 本発明に係る薬液回路システムにおいては、生理食塩水用の加圧手段224(図1)に代えて、図11のようなポンプ装置226を利用してもよい。図11では、薬液回路システムの一部のみを示している。三方活栓213より下流の構成については図1と同様のものを使用可能である。
(Second Embodiment-1-)
In the chemical circuit system according to the present invention, a pump device 226 as shown in FIG. 11 may be used in place of the pressurizing means 224 for physiological saline (FIG. 1). FIG. 11 shows only a part of the chemical circuit system. About the structure downstream from the three-way cock 213, the thing similar to FIG. 1 can be used.
 このポンプ装置226は、例えば特許第3626264号に開示されたような方式のものである。ポンプ装置226は、小型のシリンジ226aを搭載する本体部227と、そのシリンジ226aのピストン部材を進退および後退させるピストン駆動機構(不図示)を備えている。 The pump device 226 is of the type disclosed in Japanese Patent No. 3626264, for example. The pump device 226 includes a main body 227 on which a small syringe 226a is mounted, and a piston drive mechanism (not shown) that moves the piston member of the syringe 226a back and forth.
 このポンプ装置226による生理食塩水の輸送を実現するために、図11の構成では、回路の一部が図1のものから変更されている。具体的には、デュアルチェックバルブ215A、215Bの代わりT字コネクタ215C、215Dが使用されており、両コネクタ間に一方弁V-1が配置されている。なお、一方弁V-1は、図11の三角マークで示すように、下流側への流れは許容しその逆方向の流れは許容しないように配置されている。他の一方弁V-2~V4の流れ規制方向に関しても、これと同様に図11の三角マークの方向に従う。 In order to realize the transportation of the physiological saline by the pump device 226, in the configuration of FIG. 11, a part of the circuit is changed from that of FIG. Specifically, T-shaped connectors 215C and 215D are used instead of the dual check valves 215A and 215B, and one valve V-1 is disposed between the two connectors. The one-way valve V-1 is arranged so as to allow the flow to the downstream side and not to allow the flow in the opposite direction, as indicated by the triangular mark in FIG. The flow restriction directions of the other one-way valves V-2 to V4 also follow the direction of the triangular mark in FIG.
 T字コネクタ215Cと造影剤チャンバ221とを結ぶライン205上には、チャンバ221に近い側から順に、接続コネクタ234、点滴用チャンバ233、エアセンサ231、一方弁V-2が配置されている。なお、これらの構成要素234、233、231の配置については適宜変更可能である。 On the line 205 connecting the T-shaped connector 215C and the contrast medium chamber 221, a connector 234, an infusion chamber 233, an air sensor 231 and a one-way valve V-2 are arranged in this order from the side close to the chamber 221. The arrangement of these components 234, 233, 231 can be changed as appropriate.
 コネクタ215Dと生理食塩水チャンバ223とを結ぶ生理食塩水ライン206は途中で2つに別れており、分岐したライン209がポンプ装置226へと延びている。ライン209は、一例としてT字コネクタでライン206に接続されている。図11に示すように、ライン206には2つの一方弁V-3、V-4が配置されている。 The physiological saline line 206 connecting the connector 215D and the physiological saline chamber 223 is divided into two on the way, and the branched line 209 extends to the pump device 226. As an example, the line 209 is connected to the line 206 by a T-shaped connector. As shown in FIG. 11, two one-way valves V-3 and V-4 are arranged on the line 206.
 コネクタ215Dと三方活栓213との間にも、一方弁V-5が1つ設けられている。なお、一方弁V-5は省略されてもよい。一方弁V-5がある場合、該一方弁よりも下流の回路をディスポーザブルとしてもよい。あるいは、一方弁V-5の有無に関わらず、コネクタ215Dよりも下流の回路をディスポーザルとしてもよい。
 また、三方活栓213に薬液チューブ(不図示)が接続され、その薬液チューブ経由で患者に向けて薬液を注入するようにしてもよい。
One one-way valve V-5 is also provided between the connector 215D and the three-way cock 213. The one-way valve V-5 may be omitted. When there is one valve V-5, a circuit downstream from the one valve may be made disposable. Alternatively, a circuit downstream from the connector 215D may be used as the disposal regardless of the presence or absence of the one-way valve V-5.
Further, a chemical liquid tube (not shown) may be connected to the three-way cock 213, and the chemical liquid may be injected toward the patient via the chemical liquid tube.
 上述のように構成された図11の薬液回路システムでは、ポンプ装置226を動作させて小型シリンジ226aのピストン部材を進退移動させることで、(i)チャンバ223からシリンジ226a内への生理食塩水の吸引と、(ii)小型シリンジ226aからの生理食塩水の吐出が繰り返される。これにより、生理食塩水が患者に向けて注入される。 In the chemical circuit system of FIG. 11 configured as described above, by operating the pump device 226 to move the piston member of the small syringe 226a forward and backward, (i) physiological saline from the chamber 223 into the syringe 226a Suction and (ii) discharge of physiological saline from the small syringe 226a are repeated. Thereby, physiological saline is inject | poured toward a patient.
 なお、図11の構成では、一例として、生理食塩水チャンバ223の重量を計測する荷重センサ223Sが設けられている。不図示の制御装置は、この荷重センサ223Sの出力値もしくはそれを荷重に変換したものに基づき、その値が所定の設定値以下であるかどうか(すなわち、生理食塩水の残量がある基準値以下となったかどうか)を判定する。そして、所定の設定値以下と判定した場合には、術者に対して所定の警告(例えばランプの点灯、メッセージの表示、音もしくは音声の出力等)を発する。 In the configuration of FIG. 11, as an example, a load sensor 223 </ b> S that measures the weight of the physiological saline chamber 223 is provided. The control device (not shown) is based on the output value of the load sensor 223S or a value obtained by converting the load sensor 223S into a load. Whether or not) When it is determined that the value is equal to or less than a predetermined set value, a predetermined warning (for example, lighting of a lamp, display of a message, output of sound or sound, etc.) is issued to the surgeon.
 当然ながら、上記のような荷重センサ223Sは、図1の実施形態の薬液回路システムにおいても利用可能である。 Of course, the load sensor 223S as described above can also be used in the chemical circuit system of the embodiment of FIG.
 例えば図11の薬液回路システムにおいてエアセンサ231を省略するために、点滴用チャンバに一例として特開平9-117505に開示されているような浮遊する弁体を有するコネクタを利用することもでき、これにより、患者ライン側へのエアの混入が防止される。また、その弁体の位置に基づき空になったか否かを判定し、空になっている場合には注入を停止する等の制御を行うようにしてもよい。 For example, in order to omit the air sensor 231 in the chemical circuit system of FIG. 11, a connector having a floating valve body as disclosed in Japanese Patent Application Laid-Open No. 9-117505 can be used as an example for the drip chamber. , Air contamination on the patient line side is prevented. Further, it may be determined based on the position of the valve body whether or not it is empty, and if it is empty, control such as stopping injection may be performed.
 図11の薬液回路システムは下記の薬液回路を含むものである:
 血管造影に用いられる医療用の薬液回路であって、
 造影剤チャンバに接続される造影剤ラインと、
 生理食塩水チャンバに接続される生理食塩水ラインと、
 シリンジに接続されるシリンジラインと、
 造影剤または生理食塩水を患者に向けて送るための患者ラインと、
 前記各ラインが接続されるベースライン部であって、前記造影剤ラインおよび前記生理食塩水ラインがそれぞれT字状に接続されるベースライン部と、
 を備え、さらに、
a:(i)液体が前記ベースライン部の上流側に向かって引かれた場合には、造影剤がライン内から前記ベースライン部内に流れ、(ii)液体が前記ベースライン部の上流側から下流側に向けて押された場合には、該弁手段を通過してその方向に液体が流れるように構成された第1の弁手段(V-1、V-2)と、
b:液体が前記ベースライン部の上流側から下流側に向けて押された場合にその方向に液体が流れるのを許容し、逆向きの流れは許容しない第2の弁手段(V-1)と、
c:生理食塩水を送る手段によって前記生理食塩水チャンバから生理食塩水が送られる際に、生理食塩水の患者ライン側への流れは許容し、シリンジライン側への流れは許容しない第3の弁手段(V-3、V-1)と、
 を備える、医療用の薬液回路。
The chemical circuit system of FIG. 11 includes the following chemical circuit:
A medical chemical circuit used for angiography,
A contrast agent line connected to the contrast agent chamber;
A saline line connected to the saline chamber;
A syringe line connected to the syringe;
A patient line for delivering contrast media or saline to the patient;
A baseline part to which each line is connected, wherein the contrast medium line and the physiological saline line are each connected in a T-shape; and
In addition,
a: (i) When the liquid is drawn toward the upstream side of the baseline portion, the contrast medium flows from the line into the baseline portion, and (ii) the liquid flows from the upstream side of the baseline portion. A first valve means (V-1, V-2) configured to pass through the valve means and flow liquid in that direction when pushed toward the downstream side;
b: Second valve means (V-1) which allows the liquid to flow in the direction when the liquid is pushed from the upstream side to the downstream side of the baseline portion but does not allow the reverse flow. When,
c: When the physiological saline is sent from the physiological saline chamber by the physiological saline feeding means, the physiological saline is allowed to flow to the patient line side, and the flow to the syringe line side is not allowed. Valve means (V-3, V-1);
A medical chemical circuit comprising:
(第2の実施形態-2-)
 図16は、本発明の他の一形態の薬液回路および薬液回路システムを示している。なお、図16の回路構成は基本的には図11のものと同様のものであってもよく、図11と同一機能の構造部には同一もしくは対応する(200番台を600番台に替えて示している)符号を付している。
(Second Embodiment-2-)
FIG. 16 shows a chemical circuit and a chemical circuit system according to another embodiment of the present invention. The circuit configuration of FIG. 16 may be basically the same as that of FIG. 11, and is the same as or corresponds to the structural part having the same function as that of FIG. 11 (shown by replacing the 200 series with the 600 series). Are attached).
 図16においては、符号605が造影剤ライン、符号606が生理食塩水ライン、符号607がトランスデューサライン、符号609が生理食塩水ライン606から分岐したライン、符号608が患者ライン、符号610がベースライン部である。符号621は造影剤チャンバであり、符号623が生理食塩水チャンバである。符号633は点滴用チャンバであり、この点滴用チャンバ633はその上部に挿入針が一体的に形成された従来公知のものであってもよい。符号V-1~V4は図11と同様の構造および同様の配置の一方弁である。符号615C~615FはT字コネクタであり、符号641、642、643は接続部材である。なお、例えばコネクタ615Cおよび615Dの少なくとも一方を上述したようなデュアルチェックバルブとしてもよい。 In FIG. 16, reference numeral 605 is a contrast medium line, reference numeral 606 is a physiological saline line, reference numeral 607 is a transducer line, reference numeral 609 is a line branched from the physiological saline line 606, reference numeral 608 is a patient line, and reference numeral 610 is a baseline. Part. Reference numeral 621 is a contrast medium chamber, and reference numeral 623 is a physiological saline chamber. Reference numeral 633 denotes an infusion chamber, and the infusion chamber 633 may be a conventionally known one in which an insertion needle is integrally formed thereon. Reference numerals V-1 to V4 denote one-way valves having the same structure and the same arrangement as those in FIG. Reference numerals 615C to 615F denote T-shaped connectors, and reference numerals 641, 642, and 643 denote connection members. For example, at least one of the connectors 615C and 615D may be a dual check valve as described above.
 図16の回路構成と図11の回路との主要な相違点は下記の通りである:
-シリンジポンプ500が、ダブルパッキン式のシリンジ550(詳細下記)を有するものである。
-一方弁V-5(図11参照)が省略されている。
-トランスデューサライン607上に、リリースバルブ401A(詳細下記)が配置されている。
The main differences between the circuit configuration of FIG. 16 and the circuit of FIG. 11 are as follows:
The syringe pump 500 has a double packing type syringe 550 (detailed below).
The one-way valve V-5 (see FIG. 11) is omitted.
A release valve 401A (details below) is arranged on the transducer line 607;
 なお、下記で特に説明しない事項については、図11を参照して既に説明した内容もしくは図1を参照して既に説明した内容を適用可能であることに留意されたい。 It should be noted that the contents already described with reference to FIG. 11 or the contents already described with reference to FIG. 1 can be applied to matters not specifically described below.
 シリンジポンプ500(図16)で使用されるシリンジ550について図17を参照して説明する。このシリンジ550は、例えば特許第3639095に開示されるような塵埃防止型シリンジであって:
 中空のシリンダ部材551と、
 該シリンダ部材551内をその軸方向に摺動する2段のピストン553、554が形成されたピストン部材557と、
 を有するものであり、
 1段目および2段目のピストン553、554の外周部には水密性を確保するための環状のシール部材R1、R2が設けられている。該シール部材R1、R2間の距離が、一例で、所定の注入量を吸引するのに必要な1段目のピストン553のストローク量と等しい距離に設定されていてもよい。シール部材の材質は、一例で、エラストマー等の弾性部材であってもよい。
A syringe 550 used in the syringe pump 500 (FIG. 16) will be described with reference to FIG. The syringe 550 is a dust-proof syringe as disclosed in, for example, Japanese Patent No. 3639095:
A hollow cylinder member 551;
A piston member 557 formed with two- stage pistons 553 and 554 that slide in the axial direction in the cylinder member 551;
Having
Annular seal members R1 and R2 for ensuring watertightness are provided on the outer periphery of the first and second pistons 553 and 554. For example, the distance between the seal members R1 and R2 may be set to a distance equal to the stroke amount of the first-stage piston 553 necessary for sucking a predetermined injection amount. The material of the seal member is an example, and may be an elastic member such as an elastomer.
 具体的には、ピストン部材557は、1段目のピストン553の前面がシリンダ部材551の先端部内面に当接または実質的に当接する位置(吸引前)と、所定の注入量を吸引するために所定のストローク分だけ移動した位置(吸引後)との間を往復移動するように構成されている。2段目のピストン554は1段目のピストン553よりも後ろ側に配置されている。シールリングR1、R2の断面形状は特に限定されるものではない。例えば、断面が円形、楕円形、矩形、多角形、D字経など、種々のものを利用できる。 Specifically, the piston member 557 sucks a predetermined injection amount at a position (before suction) where the front surface of the first-stage piston 553 contacts or substantially contacts the inner surface of the front end of the cylinder member 551. It is configured to reciprocate between a position moved by a predetermined stroke (after suction). The second-stage piston 554 is disposed behind the first-stage piston 553. The cross-sectional shape of the seal rings R1 and R2 is not particularly limited. For example, various cross-sections such as a circle, an ellipse, a rectangle, a polygon, and a D-shape can be used.
 ピストン部材557の基端部には、シリンジポンプの不図示の把持部材によって把持される凹部577aが形成されている。シリンジポンプの駆動機構(不図示)からの力を受けて、ピストン部材557はシリンダ部材551に対して往復移動するようになっている。これにより、シリンジ550への薬液の吸引およびシリンジ550からの薬液の送出が繰り返され、ポンプとして作用することとなる。 A concave portion 577 a that is gripped by a gripping member (not shown) of the syringe pump is formed at the base end portion of the piston member 557. The piston member 557 reciprocates with respect to the cylinder member 551 in response to a force from a drive mechanism (not shown) of the syringe pump. As a result, the suction of the chemical liquid to the syringe 550 and the delivery of the chemical liquid from the syringe 550 are repeated to act as a pump.
 なお、例えば特許第4367911に開示されているようなポンプシステムを用いてピストン部材を往復移動させてもよい。この場合、シリンダ部材に位置規制片が設けられたシリンジをポンプシステムに装着するようにしてもよい。 For example, the piston member may be reciprocated using a pump system as disclosed in Japanese Patent No. 4367911. In this case, a syringe having a position restriction piece on the cylinder member may be attached to the pump system.
 図17のピストン部材557においては、シール部材R1、R2間の距離が、およそ、1段目のピストン553が所定の注入量を吸引するのに必要なストロークと等しい距離としてある。このような構成により、外気中の塵埃等の不衛生なものが第2のピストン554のシール部材R2よりも内部に進入するが防止され、両ピストン553、554間の空間Sが滅菌状態に保たれ、ひいては、シリンジ550内に吸引される薬液をも衛生に保つことができる。 In the piston member 557 in FIG. 17, the distance between the seal members R1 and R2 is approximately equal to the stroke required for the first-stage piston 553 to suck a predetermined injection amount. With this configuration, unsanitary things such as dust in the outside air are prevented from entering the inside of the seal member R2 of the second piston 554, and the space S between the pistons 553 and 554 is maintained in a sterilized state. Therefore, the chemical liquid sucked into the syringe 550 can be kept hygienic.
 シリンジ550は、一例として、次のような変更がなされてもよい。
-シール部材R1および/またはR2が、例えば一体成形などにより、ピストンに一体的に設けられる。
-シール部材R2が嵌められていない。この場合、2段目のピストンの外周のシール性は確保されていないものの、同ピストンによって、同ピストンより内部への異物(例えば埃など)の侵入が防止されるようになっていることも好ましい。
-1段目のピストンに関し、その前面部から外周部にかけての範囲が弾性部材で構成される。
-少なくとも一方のピストン全体を弾性部材で構成する。
-ピストン553、554間の空間に、滅菌作用を有するガスを充填する。
-シール部材R1、R2間の距離が、1段目のピストンの上記ストロークよりも長くもしくは短く設定されている。
For example, the syringe 550 may be modified as follows.
The sealing member R1 and / or R2 is provided integrally with the piston, for example by integral molding.
-The sealing member R2 is not fitted. In this case, although the sealing performance of the outer periphery of the second-stage piston is not ensured, it is also preferable that the piston prevents foreign matter (such as dust) from entering the inside of the piston. .
The range from the front surface portion to the outer peripheral portion of the first-stage piston is constituted by an elastic member.
The entire at least one piston is made of an elastic member;
The space between the pistons 553, 554 is filled with a gas having a sterilizing effect.
The distance between the sealing members R1, R2 is set longer or shorter than the stroke of the first stage piston.
 また、シリンジ550としては、円筒型のシリンダ部材551の外周面に回転防止のための翼状部材が形成されていてもよい。 Further, as the syringe 550, a wing-like member for preventing rotation may be formed on the outer peripheral surface of the cylindrical cylinder member 551.
 以上のように構成された図16の薬液回路システム600においても、図1の構成同様、(i)インジェクタを動作させ、造影剤チャンバ621から薬液シリンジ651内へと造影剤を吸引するとともに、その造影剤を患者に向けて押し出す注入動作と、(ii)シリンジポンプ500を動作させ、生理食塩水チャンバ623内の生理食塩水を患者に向けて注入する動作とを、術者による活栓切換作業などを特に要することなく、正しく実施することができる。 In the chemical circuit system 600 of FIG. 16 configured as described above, as in the configuration of FIG. 1, (i) the injector is operated to suck the contrast agent from the contrast agent chamber 621 into the chemical syringe 651, and An injection operation of pushing the contrast agent toward the patient, and (ii) an operation of operating the syringe pump 500 to inject the physiological saline in the physiological saline chamber 623 toward the patient, such as a stopcock switching operation by an operator Can be carried out correctly without any special requirements.
 なお、図16のようなシステムにおいて、薬液シリンジ651(筒状のシリンダ部材とそれにスライド自在に挿入されたピストン部材とを有する)に代えて、上述したシリンジ550のような構造のシリンジを用いてもよい。 In the system shown in FIG. 16, instead of the chemical syringe 651 (having a cylindrical cylinder member and a piston member slidably inserted therein), a syringe having a structure like the above-described syringe 550 is used. Also good.
 また、第2ピストンは図18のような構成となっていてもよい。この第2ピストン554では、ピストン外周部にシール部材R2が取り付けられており、ピストン外周部から中心に向かって形成された溝554aとシール部材R2との間にガス通路558が形成されている。このガス通路558を通じて、第1ピストンと第2ピストンとの間に滅菌ガスが封入されてもよい。ガス通路558の大きさは適宜変更可能であるが、一例として、ガスを封入でき、ホコリ等の異物は通過しにくい程度のサイズであることも好ましい。 Further, the second piston may be configured as shown in FIG. In the second piston 554, a seal member R2 is attached to the outer periphery of the piston, and a gas passage 558 is formed between a groove 554a formed from the outer periphery of the piston toward the center and the seal member R2. Sterile gas may be sealed between the first piston and the second piston through the gas passage 558. The size of the gas passage 558 can be changed as appropriate, but as an example, it is also preferable that the gas passage 558 has a size that allows gas to be sealed and that foreign matters such as dust hardly pass through.
 図18の第2のピストンには、滅菌ガスを封入するための小孔554bが形成されていてもよい。図18では1つのみが図示されているが、小孔554bは1つまたは複数であってもよい。溝554aと小孔554bとの両方を設けてもよいし、一方のみを設けてもよい。 18 may be formed with a small hole 554b for enclosing a sterilizing gas. Although only one is shown in FIG. 18, the small hole 554b may be one or more. Both the groove 554a and the small hole 554b may be provided, or only one of them may be provided.
(リリースバルブ)
 図14Aは図16の構成で用いられるリリースバルブの断面図である。図14Bは、同リリースバルブの軸部材を示す正面図および底面図である。
(Release valve)
14A is a cross-sectional view of a release valve used in the configuration of FIG. FIG. 14B is a front view and a bottom view showing the shaft member of the release valve.
 このリリースバルブ401Aは、ケーシング410を構成する部材として、中空の本体部材411と、その下部に接続されたチューブ接続部材412と、本体部材411の上端開口部を閉塞するキャップ部材413とを有している。また、本体部材411の内部には、上方および下方に移動可能に配置された軸部材425が配置されている。軸部材425には2つのシール部材428、429が設けられ、また、軸部材425の一部にはフランジ部425fが形成されている。各シール部材428、429は、一例として、弾性部材からなる円盤状のものであってもよい。 The release valve 401A includes a hollow main body member 411, a tube connection member 412 connected to a lower portion thereof, and a cap member 413 that closes an upper end opening of the main body member 411 as members constituting the casing 410. ing. In addition, a shaft member 425 is disposed inside the main body member 411 so as to be movable upward and downward. The shaft member 425 is provided with two seal members 428 and 429, and a flange portion 425f is formed on a part of the shaft member 425. As an example, each of the sealing members 428 and 429 may be a disk-shaped member made of an elastic member.
 軸部材425は、コイルスプリングS1によって上方に付勢されており(図14)、この状態では、フランジ部425fがシール部材429に押し当たる。この状態では、接続部材412の下端開口部412aから本体部材411の側方開口部411aに向けて(あるいはその逆方向)液体が流れることはない。 The shaft member 425 is biased upward by the coil spring S1 (FIG. 14), and in this state, the flange portion 425f presses against the seal member 429. In this state, liquid does not flow from the lower end opening 412a of the connection member 412 toward the side opening 411a of the main body member 411 (or in the opposite direction).
 一方、キャップ部材413の中央部から上方に突出した軸部材425の端部を押すと、フランジ部425fが下方に移動するので、液体の流路(詳細は不図示)が開放され、これにより、接続部材412の下端開口部412aから本体部材411の側方開口部411aに向けて(あるいはその逆方向)液体が流れることができるようになる。なお、液体の流路に関して、例えば、軸部材425の外周部にその長手方向に沿って形成された溝によって流路の一部が形成されていてもよい。本実施形態では、図14Bのように、軸部材425の下端側425aが一例として断面十字形とされている。なお、必ずしも十字形に限定されるものではなく種々の形状に変更されてもよい。 On the other hand, when the end portion of the shaft member 425 protruding upward from the center portion of the cap member 413 is pushed, the flange portion 425f moves downward, so that the liquid flow path (not shown in detail) is opened. The liquid can flow from the lower end opening 412a of the connection member 412 toward the side opening 411a of the main body member 411 (or in the opposite direction). Regarding the liquid flow path, for example, a part of the flow path may be formed by a groove formed along the longitudinal direction of the outer periphery of the shaft member 425. In the present embodiment, as shown in FIG. 14B, the lower end side 425a of the shaft member 425 has a cross-shaped cross section as an example. The shape is not necessarily limited to a cross shape, and may be changed to various shapes.
 なお、このリリースバルブ401Aに関しても、例えば第1の実施形態で説明した自動切替機300(図2B)のような装置を利用して、軸部材425の押圧/解除を行うようにしてもよい。切替機は、注入装置によって動作が制御されるものであってもよいし、術者によって手動で操作されてもよい。 For the release valve 401A, the shaft member 425 may be pressed / released by using a device such as the automatic switching machine 300 (FIG. 2B) described in the first embodiment. The operation of the switching machine may be controlled by an injection device, or may be manually operated by an operator.
 他にも、図15のようなリリースバルブ401Bを用いてもよい。図15のリリースバルブ401Bは、ケーシング410を構成する部材として、中空の本体部材411と、その上端開口部を閉塞するキャップ部材413とを有している。本体部材411の内部には、上方および下方に移動可能に配置された軸部材425が配置されている。軸部材425には、1つのシール部材429と、OリングR1が設けられている。キャップ部材413から上方に突出した軸部材425の上端には、内部に流路が形成された押圧部材416が取り付けられている。押圧部材416は、液体の出入口となる側方開口部416aを有している。 Alternatively, a release valve 401B as shown in FIG. 15 may be used. The release valve 401B of FIG. 15 includes a hollow main body member 411 and a cap member 413 that closes the upper end opening as members constituting the casing 410. A shaft member 425 is arranged inside the main body member 411 so as to be movable upward and downward. The shaft member 425 is provided with one seal member 429 and an O-ring R1. A pressing member 416 having a flow path formed therein is attached to the upper end of the shaft member 425 protruding upward from the cap member 413. The pressing member 416 has a side opening 416a serving as a liquid inlet / outlet.
 このように構成されたリリースバルブ401Bにおいても、軸部材425を押していない状態では、コイルスプリングS1の付勢力によってフランジ部425fがシール部材429に押し当てられ、その結果、下端開口部411aから押圧部材416の側方開口部416aに向けて(あるいはその逆方向)液体が流れないようになっている。一方、キャップ部材軸部材425を押すと、液体の流路(詳細は不図示)が開放され、これにより液体が流れることができるようになる。 Even in the release valve 401B configured as described above, when the shaft member 425 is not pressed, the flange portion 425f is pressed against the seal member 429 by the urging force of the coil spring S1, and as a result, the pressing member is pressed from the lower end opening 411a. The liquid is prevented from flowing toward the side opening 416a of 416 (or the opposite direction). On the other hand, when the cap member shaft member 425 is pushed, the liquid flow path (not shown in detail) is opened, thereby allowing the liquid to flow.
(別の形態に係る回路構成)
 図19の回路構成について説明する。この薬液回路601Pは、先に述べた図11や図16のものと一部類似しているが、回路の一部がディスポーザブル回路になっている点や、チューブ(ライン)を閉塞するクランピング機構が設けられている点等で相違している(詳細下記)。
(Circuit configuration according to another embodiment)
The circuit configuration of FIG. 19 will be described. This chemical circuit 601P is partially similar to that of FIG. 11 and FIG. 16 described above, but a part of the circuit is a disposable circuit and a clamping mechanism for closing the tube (line). Is different (details below).
 なお、上記形態と同様の構成については重複する説明は省略する。また、以下に説明する内容は本明細書の他の技術事項と適宜組み合わせて利用できるものであることに留意されたい。本発明は図面および/または明細書に例示された具体的構成に限定されるものではなく、必要に応じて適宜他の構成、部品等を利用してもよい。 In addition, about the structure similar to the said form, the overlapping description is abbreviate | omitted. It should be noted that the contents described below can be used in combination with other technical matters in this specification as appropriate. The present invention is not limited to the specific configurations illustrated in the drawings and / or the specification, and other configurations, components, and the like may be used as needed.
 図19の薬液回路システムにおける薬液回路(601P)は、一例で次のように表現できる:
 造影剤チャンバ(621)に接続される造影剤ライン(605)と、
 生理食塩水チャンバ(623)に接続される生理食塩水ライン(606)と、
 薬液シリンジ(651)に接続される液体流路と、
 造影剤または生理食塩水を患者に向けて送るための患者ライン(608)と、
 各ラインが接続されるベースライン部(610)と、
 を備え、造影剤をいったん薬液シリンジ(651)内に吸引したのち該シリンジから患者に向けて注入する薬液注入に用いられる薬液回路(601P)であって、
 さらに、次のように構成されている;
(i)液体がベースライン部の上流側に向かって引かれた場合には造影剤が造影剤ライン内からベースライン部内に流れるとともに、(ii)液体がベースライン部の上流側から下流側に向けて押された場合には、造影剤ライン内に逆流することなく、ベースライン部の上流側から下流側へと液体が流れることを許容する第1の弁デバイス(V-1、V-2)と、
 生理食塩水ラインからベースライン部側への液体が流れは許容するがその逆は許容しない第2の弁デバイス(V-3)と、を備える:
 そして、ベースライン部(610)と生理食塩水ライン(606)との接続部より下流側のディスポーザブル回路部分(601P-1)が、好ましくは一方弁(V-5)を介して、取外し自在に構成されている。
The chemical circuit (601P) in the chemical circuit system of FIG. 19 can be expressed as follows as an example:
A contrast agent line (605) connected to the contrast agent chamber (621);
A saline line (606) connected to a saline chamber (623);
A liquid flow path connected to the chemical syringe (651);
A patient line (608) for delivering contrast agent or saline to the patient;
A baseline portion (610) to which each line is connected;
A chemical circuit (601P) used for injecting a contrast medium into the chemical syringe (651) and then injecting the contrast medium from the syringe toward the patient,
In addition, it is structured as follows:
(I) When the liquid is drawn toward the upstream side of the baseline portion, the contrast agent flows from the contrast agent line into the baseline portion, and (ii) the liquid flows from the upstream side to the downstream side of the baseline portion. The first valve device (V-1, V-2) that allows the liquid to flow from the upstream side to the downstream side of the baseline portion without flowing back into the contrast agent line when pushed )When,
A second valve device (V-3) that allows liquid to flow from the saline line to the base line side but not vice versa:
The disposable circuit portion (601P-1) on the downstream side of the connection portion between the base line portion (610) and the physiological saline line (606) is preferably detachable via a one-way valve (V-5). It is configured.
 このような回路構成おいても、(i)一例でインジェクタ(不図示)のピストン駆動機構を駆動してピストンを引くことで、造影剤チャンバ(621)から薬液シリンジ(651)内へと造影剤を吸引するとともに、その後、その造影剤を患者に向けて押し出す動作、および/または、(ii)シリンジポンプ(ポンプ手段)(500)によって、生理食塩水チャンバ(623)内の生理食塩水をシリンジ側に逆流させることなく患者に向けて注入していく動作とを行うことができる。すなわち、このような回路構成によれば、術者による活栓切換作業などを特に要することなく、造影剤の吸引および注入等を正しく実施することができる。 Even in such a circuit configuration, (i) in one example, by driving a piston drive mechanism of an injector (not shown) and pulling the piston, the contrast agent is transferred from the contrast agent chamber (621) into the drug solution syringe (651). And / or (ii) a syringe pump (pump means) (500) to cause the saline in the saline chamber (623) to be syringed by the action of pushing the contrast medium toward the patient and / or It is possible to perform the operation of injecting toward the patient without backflowing to the side. That is, according to such a circuit configuration, it is possible to correctly perform the suction and injection of the contrast agent without requiring a stopcock switching operation by the operator.
(回路構成の具体的説明)
 図19の薬液回路601Pにおいては、ディスポーザブル回路部分601P-1が、一方弁V-5やコネクタ等を介して、コネクタ615Dから下流側に延びるライン608の末端に対して着脱自在に構成されている。なお、この例では一方弁V-5を使っているが、単なるコネクタ等によって着脱自在としてもよい。
(Specific description of circuit configuration)
In the chemical circuit 601P of FIG. 19, the disposable circuit portion 601P-1 is configured to be detachable with respect to the end of a line 608 extending downstream from the connector 615D via a one-way valve V-5, a connector, or the like. . In this example, the one-way valve V-5 is used, but it may be detachable by a simple connector or the like.
 この例では、ディスポーザブル回路部分601P-1は、一方弁V-5から患者側に向かって延びるライン608と、その途中位置からトランスデューサ670側に向かって分岐したライン607とを有している。このディスポーザル回路部分601P-1のライン607およびライン608のところに、クランピング機構660が1つずつ設けられている。 In this example, the disposable circuit portion 601P-1 has a line 608 extending from the one-way valve V-5 toward the patient, and a line 607 branched from the midway position toward the transducer 670. One clamping mechanism 660 is provided at the line 607 and the line 608 of the disposal circuit portion 601P-1.
 クランピング機構660は、不図示の駆動源と、チューブを押圧する1つまたは複数のクランプ部材668とを有するものであってもよい。駆動源(不図示)からの駆動力により、クランプ部材668が動かされて、可撓性チューブを押し潰して流路を閉塞する。駆動源(不図示)としては特に限定されるものではないが、例えばモータや流体シリンダ等といった種々のアクチュエータを利用することができる。 The clamping mechanism 660 may include a drive source (not shown) and one or more clamp members 668 that press the tube. The clamp member 668 is moved by a driving force from a driving source (not shown), and the flexible tube is crushed to close the flow path. The driving source (not shown) is not particularly limited, but various actuators such as a motor and a fluid cylinder can be used.
 駆動源(不図示)の動作制御は、不図示のコントローラによって自動的に行われるものであってよい。そのようなコントローラとしては、プロセッサユニットやメモリ等を含むマイクロコンピュータであってもよく、それ自体の配置位置は何ら限定されない。 The operation control of the drive source (not shown) may be automatically performed by a controller (not shown). Such a controller may be a microcomputer including a processor unit, a memory, and the like, and its arrangement position is not limited at all.
 図19の例では、2つのクランピング機構660が互いに離れて描かれているが、これらは別々の駆動源によって駆動されるものであってもよいし、共通の駆動源によって駆動されるものであってもよい。 In the example of FIG. 19, the two clamping mechanisms 660 are drawn apart from each other, but these may be driven by different driving sources or driven by a common driving source. There may be.
 また、図19のような回路構成とした場合、さらに、次のようなもののうちの1つ、複数、または全部が採用されていてもよい:
-造影剤ライン605の途中または端部にエアセンサ631が設けられている、
-生理食塩水ライン606の途中または端部にエアセンサ631が設けられている、
-各コネクタ615C~615Fの少なくともいずれかに一方弁(チェックバルブ)の機能をもたせる、等。
Further, in the case of the circuit configuration as shown in FIG. 19, one, plural, or all of the following may be adopted:
An air sensor 631 is provided in the middle or at the end of the contrast medium line 605,
An air sensor 631 is provided in the middle or at the end of the physiological saline line 606;
-At least one of the connectors 615C to 615F has the function of a one-way valve (check valve), etc.
 なお、エアセンサ631としては上記実施形態で例示したような赤外線を利用するものであってもよいが、他にも、紫外線を利用する光学センサや、超音波を利用するセンサ等であってもよい。とりわけ、紫外線センサの場合、赤外線センサの場合と比較して、血液と薬液とを判別することや、液体中の異物を検出することを良好に行うことができるという利点がある。 The air sensor 631 may use infrared rays as exemplified in the above embodiment, but may also be an optical sensor that uses ultraviolet rays, a sensor that uses ultrasonic waves, or the like. . In particular, in the case of an ultraviolet sensor, there is an advantage that it is possible to better distinguish between blood and a chemical solution and to detect a foreign substance in the liquid as compared with an infrared sensor.
 続いて、クランピング機構660の幾つかの例について説明する。 Subsequently, some examples of the clamping mechanism 660 will be described.
 図20A(a)のクランピング機構では、チューブTを挟んで対向配置された一対のクランプ部材668a、668aが設けられている。各クランプ部材668は、チューブに当接する側に角部を有し、この角部でチューブを押圧するようになっている。 In the clamping mechanism of FIG. 20A (a), a pair of clamp members 668a and 668a arranged to face each other with the tube T interposed therebetween are provided. Each clamp member 668 has a corner portion on the side in contact with the tube, and presses the tube at the corner portion.
 もっとも、両方のクランプ部材668aがいずれも角部を有するものである必要はなく、一方のクランプ部材668aのみを図のようなものとし、他方は、平坦面で当接するクランプ部材(不図示)としてもよい。または、クランプ部材668aの角部と略相補的な形状(この例では、一例としてV型の溝)の対向面を有するクランプ部材668a′(図20B)としてもよい。 However, it is not necessary that both the clamp members 668a have corners, only one of the clamp members 668a is as shown in the figure, and the other is a clamp member (not shown) that abuts on a flat surface. Also good. Alternatively, the clamp member 668a ′ (FIG. 20B) may have a facing surface having a shape substantially complementary to the corner of the clamp member 668a (in this example, a V-shaped groove as an example).
 図20A(b)のクランピング機構では、各クランプ部材668bは、チューブに当接する側が曲面状に突出していて、この突出部でチューブTを押圧する。上記同様、一方のクランプ部材668bのみを図のようなものとし、他方は、上記同様、平坦面のクランプ部材(不図示)、または、略相補的な形状(この例では、湾曲した凹面)の対向面を有するクランプ部材(不図示)としてもよい。 In the clamping mechanism shown in FIG. 20A (b), each clamp member 668b protrudes in a curved shape on the side in contact with the tube, and the tube T is pressed by this protruding portion. As described above, only one clamp member 668b is as shown in the figure, and the other is a flat clamp member (not shown) or a substantially complementary shape (curved concave surface in this example) as described above. It is good also as a clamp member (not shown) which has an opposing surface.
 図20A(c)のクランピング機構では、各クランプ部材668cは、円形に形成されている。他方は、上記同様、平坦面のクランプ部材(不図示)、または、湾曲した凹面の対向面を有するクランプ部材(不図示)等ととしてもよい。 In the clamping mechanism of FIG. 20A (c), each clamp member 668c is formed in a circular shape. The other may be a flat clamp member (not shown), a clamp member (not shown) having a curved concave surface, or the like.
 クランプ部材は、しっかりとチューブを閉塞できるものであればその形状や素材はどのようなものであっても構わない。例えば、棒状部材(例えば、ピンクランプ;棒状部材の一端部がチューブに対する当接部となる。または、棒状部材の外周面の一部でチューブを押圧するようなものでもよい。)、板状部材、ブロック状の部材、球状部材等種々のものを用いることができる。クランプ部材は金属性であってもよいし、樹脂製であってもよい。金属性の場合、磁性体材料、非磁性体材料のいずれであってもよい。 The clamp member may have any shape or material as long as it can firmly close the tube. For example, a rod-shaped member (for example, a pin clamp; one end of the rod-shaped member serves as an abutting portion for the tube. Alternatively, the tube may be pressed by a part of the outer peripheral surface of the rod-shaped member), a plate-shaped member. Various members such as a block member and a spherical member can be used. The clamp member may be metallic or made of resin. In the case of metallicity, either a magnetic material or a nonmagnetic material may be used.
 図20A、図20Bに例示したような一対のクランプ部材の開閉動作に関して言えば、各クランプ部材がいずれもチューブ中心側に向かって進出しチューブを挟み込むものであってもよいし、可動に構成された一方のみが他方に対して進出してチューブを挟み込むものであってもよい。各クランプ部材が可動に構成されている場合、一方のクランプ部材の動作と他方のクランプ部材の動作が連動する機構となっていてもよいし、そうでなくてもよい。 As for the opening / closing operation of the pair of clamp members as illustrated in FIGS. 20A and 20B, each clamp member may advance toward the center of the tube and sandwich the tube, or may be configured to be movable. Only one of them may advance with respect to the other and sandwich the tube. When each clamp member is configured to be movable, the mechanism may be a mechanism in which the operation of one clamp member and the operation of the other clamp member are linked with each other.
 なお、材質についてのこの説明は、本発明の範囲を逸脱しない限りにおいて、クランピング機構660および/またはその付属品等を構成する任意の部材に適用しうるものである。 Note that this description of the material can be applied to any member constituting the clamping mechanism 660 and / or its accessories, etc., without departing from the scope of the present invention.
 図21のクランピング機構では、一対のクランプ部材を用いるのではなく、片方の部材のみが可動のクランプ部材668a~668cとなっており、このクランプ部材668a~668cが動かない固定側の受け面668sに向かって進退可能に構成されたものである。各クランプ部材668a~668cの形状は、図20と同様であるので、説明を省略する。 In the clamping mechanism of FIG. 21, a pair of clamp members are not used, but only one member is movable clamp members 668a to 668c, and the fixed receiving surface 668s on which the clamp members 668a to 668c do not move. It is configured to be able to move forward and backward. The shape of each of the clamp members 668a to 668c is the same as that in FIG.
 さらに、図22のような構成のクランピング機構であってもよい。このクランピング機構は、横方向に移動可能なスライド部材669を有し、このスライド部材669を所定方向(図では右方向)にスライドさせた場合には、当該スライド部材669の一部がクランプ部材668に当接して、同クランプ部材668をチューブT側に向けて移動させていき、最終的には、チューブTが閉塞される。一方、スライド部材669を反対方向にスライドさせた場合には、クランプ部材668がチューブTから後退していき、チューブTが開放される。 Furthermore, a clamping mechanism configured as shown in FIG. 22 may be used. The clamping mechanism has a slide member 669 that can move in the lateral direction. When the slide member 669 is slid in a predetermined direction (rightward in the drawing), a part of the slide member 669 is clamped. The clamp member 668 is moved toward the tube T side in contact with 668, and finally the tube T is closed. On the other hand, when the slide member 669 is slid in the opposite direction, the clamp member 668 moves backward from the tube T, and the tube T is opened.
 スライド部材669は、具体的な一例として、クランプ部材688に当接する傾斜面(カム面)669aを有するものであってもよい。スライド部材669は、例えばユーザの指によってスライドさせるようなものであってもよいし、不図示の駆動機構(アクチュエータ)によって自動的にスライドさせられるように構成されていてもよい。 The slide member 669 may have an inclined surface (cam surface) 669a that contacts the clamp member 688 as a specific example. The slide member 669 may be slid by a user's finger, for example, or may be configured to be automatically slid by a drive mechanism (actuator) (not shown).
 スライド部材669の移動方向としては、必ずしも横方向(すなわち、この場合ではチューブに沿った方向)に限定されない。図示は省略するが、例えば、チューブに対してその周方向に回転することで、その部材の一部に形成されたカム面が徐々に内部のクランプ部材(この場合、一例で球体でもよい)をチューブ側に押し付けていくものであってもよい。 The moving direction of the slide member 669 is not necessarily limited to the horizontal direction (that is, the direction along the tube in this case). Although illustration is omitted, for example, by rotating in the circumferential direction with respect to the tube, the cam surface formed in a part of the member gradually becomes an internal clamp member (in this case, a sphere may be used as an example). You may press against the tube side.
 スライド部材669の一部には、例えば、指が当接する部分にすべり止めのリブおよび/または突起(いずれも不図示)が形成されていてもよい。また、スライド部材669を動かすための駆動機構の一部が当接する受け部(あるいは係合する係合部)が形成されていてもよい。 For example, an anti-slip rib and / or a protrusion (both not shown) may be formed on a part of the slide member 669, for example, at a portion where the finger abuts. Further, a receiving part (or engaging part to be engaged) with which a part of the drive mechanism for moving the slide member 669 comes into contact may be formed.
 スライド部材669を有する構成に関し、さらに、次のような変更がなされてもよい。すなわち、スライド部材669が所定の固定位置まで動かされると当該スライド部材669の一部が他の部材に係合または嵌合してクリック感が得られるように構成されていてもよい。一例で、スライド部材669の一部が、他の部材に形成された凹部(不図示)に嵌まる、あるいは、他の部材に形成された突起部を乗り越えるといった構成としてもよい。加えて、この固定位置からスライド部材669が動かされる際、言い換えれば、固定位置から脱する際にもクリック感が得られるようになっていることがより好ましい。なお、このような変更は下記する図23の構成にも同様に適応しうるものであることは言うまでもない。 Regarding the configuration having the slide member 669, the following changes may be made. In other words, when the slide member 669 is moved to a predetermined fixed position, a part of the slide member 669 may be engaged or fitted with another member to obtain a click feeling. For example, a part of the slide member 669 may be fitted into a recess (not shown) formed on another member, or may be configured to get over a protrusion formed on the other member. In addition, when the slide member 669 is moved from the fixed position, in other words, it is more preferable that a click feeling is obtained even when the slide member 669 is removed from the fixed position. It goes without saying that such a change can be similarly applied to the configuration of FIG. 23 described below.
 クランピング機構としてはさらに、図23のようなものを利用することもできる。図23のクランピング機構は、チューブを開閉するための原理は図22のものと共通しているが、コネクタの筐体(662、詳細下記)内に配置された比較的軟質なチューブT′をクランプ部材668で押圧する構成となっている点で相違している。このような構成とする理由の1つは次のとおりである。 As the clamping mechanism, the one shown in FIG. 23 can also be used. The clamping mechanism of FIG. 23 has the same principle as that of FIG. 22 for opening and closing the tube, but a relatively soft tube T ′ disposed in the connector housing (662, detailed below) is provided. The difference is that the clamp member 668 is pressed. One reason for this configuration is as follows.
 すなわち、例えば薬液を非常に高い圧力(一例で500psi以上、具体的には800psi以上、より具体的な例として1000psi以上)で注入する場合、その圧力のために、通常の薬液チューブT(チューブT′と比較して硬質なもの)の部分は押し潰すこと非常に困難となることが想定される。そこで図23のクランピング機構では、薬液回路の他の薬液チューブTよりも相対的に軟質なチューブT′が筐体内に配置され、その軟質チューブT′を押圧して閉塞させる構成となっている。 That is, for example, when a chemical solution is injected at a very high pressure (for example, 500 psi or more, specifically 800 psi or more, more specifically 1000 psi or more), the normal chemical solution tube T (tube T It is envisaged that it will be very difficult to crush the portion that is harder than ′. Therefore, in the clamping mechanism shown in FIG. 23, a tube T ′ that is relatively softer than the other chemical solution tubes T in the chemical circuit is arranged in the casing, and the soft tube T ′ is pressed and closed. .
 軟質チューブT′を構成する場合、(i)チューブの材質を薬液回路の他のチューブのものより軟質なものとすることでチューブT′をより変形しやすいものとしてもよいし、あるいは、(ii)材質は同じであるが、チューブT′の厚みを薄くする、経を小さくする、および/またはそれらの組合せにより、チューブT′をより変形しやすいものとしてもよい。 When the soft tube T ′ is configured, (i) the tube T ′ may be more easily deformed by making the material of the tube softer than that of other tubes of the chemical circuit, or (ii) The material is the same, but the tube T ′ may be more easily deformed by reducing the thickness of the tube T ′, reducing the warp, and / or combinations thereof.
 ただし、軟質チューブT′が薬液の圧力によって膨張してしまう可能性もあるので、軟質チューブT′を包囲するように保護カバー662が設けられている。保護カバー662は、どのような形状であっても構わないが、一例で、チューブの直径より一回り大きい内径の筒状であってもよい。断面形状は円形が好ましいが、例えば、楕円形、矩形、多角形等としてもよい。保護カバー662の一部分に開口部662aが形成され、この開口部662aを介してクランプ部材668が進退移動するように構成されている。 However, since the soft tube T ′ may expand due to the pressure of the chemical solution, the protective cover 662 is provided so as to surround the soft tube T ′. The protective cover 662 may have any shape, but may be a cylindrical shape having an inner diameter that is slightly larger than the diameter of the tube. The cross-sectional shape is preferably circular, but may be, for example, an ellipse, a rectangle, or a polygon. An opening 662a is formed in a part of the protective cover 662, and the clamp member 668 is configured to move forward and backward through the opening 662a.
 保護カバー662の材質としてはどのようなものであっても構わないが、一例で、保護カバー662は樹脂成形品であってもよい。 The protective cover 662 may be made of any material, but as an example, the protective cover 662 may be a resin molded product.
 図23に例示したような構成によれば、軟質のチューブT′を押し潰すものであるので、直接、薬液チューブTの一部を押圧する場合と比較して良好にチューブの押潰し、すなわち、ラインの閉塞を行うことができ、特に、高圧の薬液注入の場合に有利である。 According to the configuration illustrated in FIG. 23, since the soft tube T ′ is crushed, the tube is crushed well compared to the case of directly pressing a part of the chemical liquid tube T, that is, The line can be closed, which is particularly advantageous in the case of high-pressure chemical solution injection.
 以上、薬液回路の種々の例や、クランピング機構の具体的な例を幾つか説明してきたが、クランピング機構の配置位置は種々変更可能である。図19を例として説明すると、薬液回路における符号A~Eで示す位置から選ばれる1つまたは複数の個所に配置されてもよい。 As described above, various examples of the chemical circuit and some specific examples of the clamping mechanism have been described. However, the arrangement position of the clamping mechanism can be variously changed. 19 will be described as an example. The chemical solution circuit may be arranged at one or a plurality of locations selected from positions indicated by symbols A to E.
 クランピング機構を複数配置する場合、それぞれのクランピング機構を同じにしてもよいし、異なったものとしてもよい。例えば、そのラインで想定される薬液の圧力に応じて、高い圧力となるところにはより高圧対応のクランピング機構を配置し、低い圧力のところには通常のクランピング機構を配置するようにすることもできる。 When a plurality of clamping mechanisms are arranged, each clamping mechanism may be the same or different. For example, according to the pressure of the chemical solution assumed in the line, a higher-pressure clamping mechanism is arranged at a high pressure, and a normal clamping mechanism is arranged at a low pressure. You can also.
(その他の構成)
-ローラ式のポンプ装置-
 なお、薬液チャンバを加圧して薬液を送り出す手段としては、図12のようなローラ式ポンプ470を利用することもできる。このポンプ470は、一例として、チャンバ223を挟むように配置された一対の押圧部材471、472を有している。押圧部材471、472うち一方が他方に対して近接することで、両部材471、472の間のチャンバ223が押圧され、これにより、チャンバ223内部の薬液が押し出される。
(Other configurations)
-Roller type pump device-
Note that a roller-type pump 470 as shown in FIG. 12 can be used as means for pressurizing the chemical chamber and delivering the chemical. As an example, the pump 470 includes a pair of pressing members 471 and 472 arranged so as to sandwich the chamber 223 therebetween. When one of the pressing members 471 and 472 comes close to the other, the chamber 223 between both the members 471 and 472 is pressed, and thereby the chemical solution inside the chamber 223 is pushed out.
 具体的な構造については適宜設計ないし変更可能であるが、一例として、ヒンジ部474で両部材が接続され、一方が他方に対して回動するようになっていてもよい。一方の部材を他方に向けて近接させるために、ローラ476が設けられていてもよい。ローラ476は、回転中心476a周りに回転しながら(駆動源があってもよいし無くてもよい)、図示矢印に示すように下方へと移動し、押圧部材471を他方の部材472に向けて押し付けるように構成されていてもよい。 Although the specific structure can be appropriately designed or changed, as an example, both members may be connected by a hinge portion 474 so that one of the members rotates with respect to the other. A roller 476 may be provided to bring one member close toward the other. The roller 476 rotates around the rotation center 476a (there may or may not be a drive source) and moves downward as indicated by an arrow in the figure, and the pressing member 471 is directed toward the other member 472. You may be comprised so that it may press.
-ピストン式のポンプ装置-
 さらに、図13のようなピストン式のポンプ480を利用することもできる。このポンプ480は、直列に接続された2つのシリンジ481、486を備えており、前方のシリンジ481の先端部がライン209(図11参照)に接続される。前方のシリンジ481内には、短いガスケット482aがスライド移動可能に配置されており、ガスケット482aの背面には突起485が形成されている。この突起485は、必ずしも形成されていなくても構わないが、ガスケット482aが後方に移動する際の可動範囲を規定する役割を果たす。
-Piston type pump device-
Furthermore, a piston type pump 480 as shown in FIG. 13 can be used. The pump 480 includes two syringes 481 and 486 connected in series, and the front end portion of the front syringe 481 is connected to the line 209 (see FIG. 11). A short gasket 482a is slidably disposed in the front syringe 481, and a protrusion 485 is formed on the back surface of the gasket 482a. The protrusion 485 is not necessarily formed, but plays a role of defining a movable range when the gasket 482a moves rearward.
 後方のシリンジ486の先端は長細く形成され、前方のシリンジ481の封止部材482bに形成された貫通孔に挿入されている。これにより、後方のシリンジ486内の液体または気体が前方のシリンジ481内に送られる、および、同シリンジ481内から吸引される、ように構成されている。なお、このポンプ480には、後方のシリンジ486のピストン部材を進退移動させる駆動手段(不図示)も設けられている。 The tip of the rear syringe 486 is formed to be thin and inserted into a through hole formed in the sealing member 482b of the front syringe 481. Thus, the liquid or gas in the rear syringe 486 is sent into the front syringe 481 and sucked from the syringe 481. The pump 480 is also provided with driving means (not shown) for moving the piston member of the rear syringe 486 back and forth.
 本発明に係る薬液回路システムにおいては、このように、図13のようなタイプのポンプ装置480を利用して、生理食塩水の吸引および注入を実施することも可能である。 In the chemical circuit system according to the present invention, it is possible to suck and inject physiological saline using the pump device 480 of the type as shown in FIG.
-タコ管-
 本発明の回路システムには従来公知の種々の構造、装置、機器を適用可能である。例えば、患者への気泡の注入を防止するために、タコ管と呼ばれる構造を回路の任意の位置に設けてもよい。一例として、図1の構成において、コネクタ217とエアセンサ232との間にタコ管を設けてもよい。なお、「タコ管」とは、内部が空洞に形成された蛸の頭部のような突起部(外形はどのようなものであってもよい)であって、回路を流れてきた気泡を捕捉するためのものである。したがって、タコ管は鉛直上方に突出するように配置されることが好ましい。また、その姿勢が変動しないように、回路システムのうちライン(チューブ)の向きが安定している箇所に設けることが好ましい。
-Octopus tube-
Various conventionally known structures, devices, and equipment can be applied to the circuit system of the present invention. For example, a structure called an octopus tube may be provided at an arbitrary position of the circuit in order to prevent air bubbles from being injected into the patient. As an example, an octopus pipe may be provided between the connector 217 and the air sensor 232 in the configuration of FIG. The “octopus tube” is a protruding part (the outer shape may be any shape) such as the head of a spear that is formed in a hollow inside, and traps bubbles flowing through the circuit. Is to do. Therefore, it is preferable that the octopus pipe is arranged so as to protrude vertically upward. Moreover, it is preferable to provide in the location where the direction of a line (tube) is stable among circuit systems so that the attitude | position may not fluctuate.
 本出願は、下記の発明を開示する。
1.造影剤チャンバに接続される造影剤ライン(605)と、
 生理食塩水チャンバに接続される生理食塩水ライン(606)と、
 薬液シリンジ(651)に接続されるシリンジライン(604)と、
 造影剤または生理食塩水を患者に向けて送るための患者ライン(608)と、
 前記各ラインが接続されるベースライン部(610)と、
 を備え、造影剤をいったん前記薬液シリンジ(651)内に吸引したのち該シリンジから患者に向けて注入する薬液注入に用いられる薬液回路(601)であって、
 さらに、
 (i)液体が前記ベースライン部(610)の上流側に向かって引かれた場合には造影剤が造影剤ライン(605)内から前記ベースライン部(610)内に流れるとともに、(ii)液体が前記ベースライン部(610)の上流側から下流側に向けて押された場合には、造影剤ライン内に逆流することなく、ベースライン部(610)の上流側から下流側へと液体が流れることを許容する第1の弁デバイス(V-1、V-2)と、
 前記生理食塩水ライン(606)側から前記ベースライン部(610)側への液体が流れは許容するがその逆は許容しない第2の弁デバイス(V-3、V-4)と、
 を備える、薬液回路。
This application discloses the following invention.
1. A contrast agent line (605) connected to the contrast agent chamber;
A saline line (606) connected to the saline chamber;
A syringe line (604) connected to the chemical syringe (651);
A patient line (608) for delivering contrast agent or saline to the patient;
A baseline portion (610) to which the lines are connected;
A chemical liquid circuit (601) used for injecting a contrast medium into the chemical liquid syringe (651) and then injecting the contrast medium from the syringe toward the patient,
further,
(I) When the liquid is drawn toward the upstream side of the baseline part (610), the contrast agent flows from the contrast medium line (605) into the baseline part (610), and (ii) When the liquid is pushed from the upstream side to the downstream side of the baseline part (610), the liquid flows from the upstream side to the downstream side of the baseline part (610) without flowing back into the contrast agent line. A first valve device (V-1, V-2) that allows the flow of
A second valve device (V-3, V-4) that allows liquid to flow from the saline line (606) side to the base line part (610) side but not vice versa;
A chemical circuit.
2.さらに、
 一端が圧力トランスデューサに接続されるとともに他端が前記ベースライン部(610)に接続されるトランスデューサライン(607)と、
 可動部材(425)を有し該トランスデューサライン(607)上に配置され、前記可動部材(425)を移動させることによって当該ラインを開閉するリリースバルブ(401A)と、
 を備える、上記記載の薬液回路。
2. further,
A transducer line (607) having one end connected to the pressure transducer and the other end connected to the baseline portion (610);
A release valve (401A) having a movable member (425) and disposed on the transducer line (607) and opening and closing the line by moving the movable member (425);
A chemical circuit as described above, comprising:
3.前記第1の弁デバイス(V-1、V-2)として、
 前記造影剤ライン(605)に設けられた一方弁(V-2)と、
 前記ベースライン部(610)に設けられた一方弁(V-1)と、
 を有する、上記記載の薬液回路。
3. As the first valve device (V-1, V-2),
A one-way valve (V-2) provided in the contrast medium line (605);
A one-way valve (V-1) provided in the baseline portion (610);
The chemical circuit according to the above, comprising:
3-1.ベースライン部と前記生理食塩水ラインとの接続部より下流側の回路部分(601P-1)が、好ましくは一方弁(V-5)を介して、交換可能に構成されている、上記記載の薬液回路(601P)。 3-1. The circuit part (601P-1) on the downstream side of the connection part between the base line part and the physiological saline line is preferably configured to be exchangeable via a one-way valve (V-5). Chemical circuit (601P).
4.上記記載の薬液回路(601)と、
 生理食塩水を前記生理食塩水チャンバから引き出すとともにその生理食塩水を前記生理食塩水ライン(606)側から前記ベースライン部(610)側へと送り込むポンプユニット(500)と、
 を備える薬液回路システム(600)。
4). A chemical circuit (601) as described above;
A pump unit (500) that draws physiological saline from the physiological saline chamber and feeds the physiological saline from the physiological saline line (606) side to the baseline part (610) side;
A chemical circuit system (600) comprising:
5.前記ポンプユニットが、
 液体をシリンジ内に吸引する動作と、その液体を押し出す動作とを繰り返して液体を移送するシリンジポンプ(500)である、
 上記記載の薬液回路システム。
5. The pump unit is
A syringe pump (500) for transferring a liquid by repeating an operation of sucking a liquid into a syringe and an operation of pushing out the liquid.
The chemical circuit system described above.
6.前記シリンジポンプのシリンジ(550)が、
 中空のシリンダ部材(551)と、
 該シリンダ部材(551)内をその軸方向に摺動する2段のピストン(553、554)が形成されたピストン部材(557)と、
 を有する塵埃防止型シリンジ(550)である、上記記載の薬液回路システム。
6). The syringe (550) of the syringe pump is
A hollow cylinder member (551);
A piston member (557) formed with two-stage pistons (553, 554) sliding in the axial direction in the cylinder member (551);
The above-described chemical circuit system, which is a dust-proof syringe (550) having
7.1段目および2段目の前記ピストン(553、554)の外周部には水密性を確保するためのシール部材(R1、R2)が設けられ、該シール部材(R1、R2)間の距離が、所定の注入量を吸引するのに必要な前記1段目のピストンのストローク量に対応する距離に設定されている、上記記載の薬液回路システム。 7. Seal members (R1, R2) for ensuring water-tightness are provided on the outer periphery of the first-stage and second-stage pistons (553, 554), and between the seal members (R1, R2). The chemical circuit system according to the above, wherein the distance is set to a distance corresponding to a stroke amount of the first stage piston necessary for sucking a predetermined injection amount.
 なお、下記のような変更が加えられてもよい。
(1)生理食塩水ラインが、チャンバではなく、生理食塩水送出デバイスに接続される。「生理食塩水送出デバイス」とは、生理食塩水を収容する何らかの収容部材と、その生理食塩水を押し出す機構を有するものである。例えば、
-チャンバ623から、一般的なシリンジに生理食塩水を一度だけ吸引し、同シリンジから生理食塩水を押し出す。
-チャンバ623やシリンジポンプ500を備えず、単に生理食塩水収容部材(例えばシリンジ等)から生理食塩水を押し出すもの。なお、この場合、シリンジは生理食塩水が予め充填されたプレフィルドタイプであってもよいし、不図示の吸引装置でシリンジ内に生理食塩水を吸引したものであってもよい。
(2)同様に、造影剤ラインおよびシリンジ651も適宜変更可能である。すなわち、
-チャンバ621から、シリンジ651に造影剤を一度だけ吸引し、同シリンジから造影剤を押し出す。
-チャンバ621から、往復型のシリンジ(シリンジ550のようなもの)に造影剤を吸引し、押し出す動作を繰り返す。
-コネクタ615C、弁V-2、ライン605等が省略され、ベースライン部610に、単に、造影剤収容部材(例えばシリンジ等)から造影剤を押し出すデバイスが接続される。なお、この場合、シリンジは造影剤が予め充填されたプレフィルドタイプであってもよいし、不図示の吸引装置でシリンジ内に造影剤を吸引したものであってもよい。
The following changes may be made.
(1) The saline line is connected to the saline delivery device, not the chamber. The “physiological saline delivery device” has a certain housing member that contains physiological saline and a mechanism that pushes out the physiological saline. For example,
-Aspirate saline from chamber 623 into a generic syringe only once and push saline out of the syringe.
A device that does not include the chamber 623 or the syringe pump 500 and simply pushes the physiological saline from a physiological saline containing member (for example, a syringe). In this case, the syringe may be a prefilled type pre-filled with physiological saline, or may be one in which physiological saline is sucked into the syringe by a suction device (not shown).
(2) Similarly, the contrast medium line and the syringe 651 can be appropriately changed. That is,
-Aspirate the contrast agent from the chamber 621 into the syringe 651 only once and push the contrast agent out of the syringe.
-Repeat the operation of sucking and extruding the contrast agent from the chamber 621 into a reciprocating syringe (such as the syringe 550).
-The connector 615C, the valve V-2, the line 605, etc. are omitted, and a device that pushes out the contrast agent from the contrast agent accommodating member (for example, a syringe) is simply connected to the baseline portion 610. In this case, the syringe may be a prefilled type in which a contrast medium is pre-filled, or may be one in which the contrast medium is sucked into the syringe by a suction device (not shown).
200 薬液回路システム
201 薬液回路
202A、202B リリースバルブ
203 可動部材
205 造影剤ライン
206 生理食塩水ライン
207 トランスデューサライン
208 患者ライン
209 ライン
210 ベースライン部
213 三方活栓
215A、215B デュアルチェックバルブ
215C、215D コネクタ
221 造影剤チャンバ
223 生理食塩水チャンバ
223S センサ
226 ポンプ装置
226a シリンジ
227 本体部
231、232 エアセンサ
251 シリンジ
260 インジェクタ
270 圧力トランスデューサ
300 切替機
301 駆動部
332 エアセンサ
401A、401B リリースバルブ
410 ケーシング
411 本体部材
412 チューブ接続部材
413 キャップ部材
425 可動部材
428、429 シール部材
470 ローラ式ポンプ
476 ローラ
480 ピストン式ポンプ
481、486 シリンジ
500 シリンジ
551 シリンダ部材
551a 先端管
553、554 ピストン
557 ピストン部材
600 液体回路システム
601P 薬液回路
601P-1 ディスポーザブル回路
604 シリンジライン
605 造影剤ライン
606 生理食塩水ライン
607 トランスデューサライン
608 患者ライン
610 ベースライン部
615C~615F T字コネクタ
621 造影剤チャンバ
623 生理食塩水チャンバ
651 薬液シリンジ
660 クランピング機構
662 保護カバー
662a 開口部
668a~668c、668a′ クランプ部材
668s 受け面
669 スライド部材
T チューブ
T′ 軟質チューブ
V-1~V-5 一方弁(弁デバイス)
 
200 Chemical liquid circuit system 201 Chemical liquid circuit 202A, 202B Release valve 203 Movable member 205 Contrast medium line 206 Saline line 207 Transducer line 208 Patient line 209 Line 210 Base line part 213 Three- way stopcock 215A, 215B Dual check valve 215C, 215D Connector 221 Contrast medium chamber 223 Saline chamber 223S Sensor 226 Pump device 226a Syringe 227 Main body part 231, 232 Air sensor 251 Syringe 260 Injector 270 Pressure transducer 300 Switching machine 301 Drive part 332 Air sensor 401A, 401B Release valve 410 Casing 411 Main body member 412 Tube connection Member 413 Cap member 425 Movable member 428, 429 Seal member 4 0 Roller type pump 476 Roller 480 Piston type pump 481, 486 Syringe 500 Syringe 551 Cylinder member 551a End pipe 553, 554 Piston 557 Piston member 600 Liquid circuit system 601P Chemical liquid circuit 601P-1 Disposable circuit 604 Syringe line 605 Contrast medium line 606 Physiology Saline line 607 Transducer line 608 Patient line 610 Base line portion 615C to 615F T connector 621 Contrast medium chamber 623 Saline chamber 651 Drug syringe 660 Clamping mechanism 662 Protective cover 662a Openings 668a to 668c, 668a ′ Clamp member 668s Receiving surface 669 Slide member T Tube T 'Soft tube V-1 to V-5 One-way valve (valve device)

Claims (8)

  1.  造影剤チャンバに接続される造影剤ラインと、
     生理食塩水チャンバに接続される生理食塩水ラインと、
     薬液シリンジに接続されるシリンジラインと、
     造影剤または生理食塩水を患者に向けて送るための患者ラインと、
     前記各ラインが接続されるベースライン部と、
     を備え、造影剤をいったん前記薬液シリンジ内に吸引したのち該シリンジから患者に向けて注入する薬液注入に用いられる薬液回路であって、
     さらに、
     (i)液体が前記ベースライン部の上流側に向かって引かれた場合には造影剤が造影剤ライン内から前記ベースライン部内に流れるとともに、(ii)液体が前記ベースライン部の上流側から下流側に向けて押された場合には、造影剤ライン内に逆流することなく、ベースライン部の上流側から下流側へと液体が流れることを許容する第1の弁デバイスと、
     前記生理食塩水ラインから前記ベースライン部側への液体が流れは許容するがその逆は許容しない第2の弁デバイスと、
     を備える、薬液回路。
    A contrast agent line connected to the contrast agent chamber;
    A saline line connected to the saline chamber;
    A syringe line connected to the chemical syringe;
    A patient line for delivering contrast media or saline to the patient;
    A baseline part to which each line is connected;
    A liquid medicine circuit that is used for liquid medicine injection for injecting a contrast medium into the liquid medicine syringe and then injecting the contrast medium from the syringe toward a patient,
    further,
    (I) When the liquid is drawn toward the upstream side of the baseline portion, the contrast medium flows from the contrast agent line into the baseline portion, and (ii) the liquid flows from the upstream side of the baseline portion. A first valve device that allows liquid to flow from the upstream side of the baseline portion to the downstream side without backflowing into the contrast agent line when pushed toward the downstream side;
    A second valve device that allows liquid to flow from the saline line to the baseline portion but not vice versa;
    A chemical circuit.
  2.  さらに、
     一端が圧力トランスデューサに接続されるとともに他端が前記ベースライン部に接続されるトランスデューサラインと、
     可動部材を有し該トランスデューサライン上に配置され、前記可動部材を移動させることによって当該ラインを開閉するリリースバルブと、
     を備える、請求項1に記載の薬液回路。
    further,
    A transducer line having one end connected to the pressure transducer and the other end connected to the baseline portion;
    A release valve that has a movable member and is disposed on the transducer line and opens and closes the line by moving the movable member;
    The chemical circuit according to claim 1, comprising:
  3.  前記第1の弁デバイスとして、
     前記造影剤ラインに設けられた一方弁と、
     前記ベースライン部に設けられた一方弁と、
     を有する、請求項1または2に記載の薬液回路。
    As the first valve device,
    A one-way valve provided in the contrast medium line;
    A one-way valve provided in the baseline portion;
    The chemical | medical solution circuit of Claim 1 or 2 which has these.
  4.  前記ベースライン部と前記生理食塩水ラインとの接続部より下流側の回路部分が交換可能に構成されている、請求項1~3のいずれか一項に記載の薬液回路。 The chemical circuit according to any one of claims 1 to 3, wherein a circuit portion downstream of a connection portion between the base line portion and the physiological saline line is configured to be replaceable.
  5.  請求項1~4のいずれか一項に記載の薬液回路と、
     生理食塩水を前記生理食塩水チャンバから引き出すとともにその生理食塩水を前記生理食塩水ライン側から前記ベースライン部側へと送り込むポンプユニットと、
     を備える薬液回路システム。
    The chemical circuit according to any one of claims 1 to 4,
    A pump unit that draws physiological saline from the physiological saline chamber and feeds the physiological saline from the physiological saline line side to the baseline portion side;
    A chemical circuit system comprising:
  6.  前記ポンプユニットが、
     液体をシリンジ内に吸引する動作と、その液体を押し出す動作とを繰り返して液体を移送するシリンジポンプである、
     請求項5に記載の薬液回路システム。
    The pump unit is
    A syringe pump that transfers liquid by repeating the operation of sucking the liquid into the syringe and the operation of pushing out the liquid.
    The chemical circuit system according to claim 5.
  7.  前記シリンジポンプのシリンジが、
     中空のシリンダ部材と、
     該シリンダ部材内をその軸方向に摺動する2段のピストンが形成されたピストン部材と、
     を有する塵埃防止型シリンジである、請求項6に記載の薬液回路システム。
    The syringe of the syringe pump is
    A hollow cylinder member;
    A piston member formed with a two-stage piston that slides in the axial direction in the cylinder member;
    The chemical circuit system according to claim 6, which is a dust-proof syringe having
  8.  1段目および2段目の前記ピストンの外周部には水密性を確保するためのシール部材が設けられ、該シール部材間の距離が、所定の注入量を吸引するのに必要な前記1段目のピストンのストローク量に対応する距離に設定されている、
     請求項7に記載の薬液回路システム。
     
    A seal member for ensuring water tightness is provided on the outer periphery of the first and second stage pistons, and the distance between the seal members is the first stage required for sucking a predetermined injection amount. Set to the distance corresponding to the stroke amount of the eye piston,
    The chemical circuit system according to claim 7.
PCT/JP2013/085207 2012-12-28 2013-12-27 Chemical liquid circuit and chemical liquid system using same WO2014104338A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014554610A JPWO2014104338A1 (en) 2012-12-28 2013-12-27 Chemical circuit and chemical circuit system using the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012288550 2012-12-28
JP2012-288550 2012-12-28

Publications (1)

Publication Number Publication Date
WO2014104338A1 true WO2014104338A1 (en) 2014-07-03

Family

ID=51021401

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/085207 WO2014104338A1 (en) 2012-12-28 2013-12-27 Chemical liquid circuit and chemical liquid system using same

Country Status (2)

Country Link
JP (3) JPWO2014104338A1 (en)
WO (1) WO2014104338A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017006637A1 (en) * 2015-07-07 2017-01-12 大塚テクノ株式会社 Infusion set and method for using same
JP2017143851A (en) * 2016-02-15 2017-08-24 株式会社根本杏林堂 Clamp, closing device, and medical liquid circuit
CN107638610A (en) * 2017-09-22 2018-01-30 深圳市信冠机电有限公司 A kind of automatic injection system
WO2019187690A1 (en) * 2018-03-29 2019-10-03 テルモ株式会社 Infusion device and syringe pump
JP2019187606A (en) * 2018-04-20 2019-10-31 株式会社メテク Infusion circuit
WO2020004581A1 (en) * 2018-06-29 2020-01-02 株式会社サーキュラス Medicinal liquid injecting device
WO2020158830A1 (en) * 2019-01-29 2020-08-06 株式会社サーキュラス Opening/closing unit drive mechanism for drug solution circuit, and drug solution injection device
KR20200140073A (en) * 2019-06-05 2020-12-15 가톨릭대학교 산학협력단 Extending Infusion Pump and Method for Using the Same
US11229750B2 (en) 2020-04-06 2022-01-25 Veloject, Llc Injection device
WO2023199993A1 (en) * 2022-04-14 2023-10-19 株式会社根本杏林堂 Medical liquid injection device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3639095B2 (en) * 1997-09-10 2005-04-13 株式会社根本杏林堂 Dust-proof syringe
JP2007532234A (en) * 2004-04-12 2007-11-15 メドラッド インコーポレーテッド Fluid transfer system, pressure isolation mechanism, injector control mechanism, and method using the same
JP2008000201A (en) * 2006-06-20 2008-01-10 Sumitomo Heavy Ind Ltd Dispensing and administering apparatus for radioactive chemical

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4034528B2 (en) * 2001-04-17 2008-01-16 住友重機械工業株式会社 Dispensing / dosing device for radioactive liquid
JP2006017660A (en) * 2004-07-05 2006-01-19 Universal Giken:Kk Radioactive quantity detecting sensor, method of measuring radioactive quantity using the sensor, and radioactive chemical automatic administration device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3639095B2 (en) * 1997-09-10 2005-04-13 株式会社根本杏林堂 Dust-proof syringe
JP2007532234A (en) * 2004-04-12 2007-11-15 メドラッド インコーポレーテッド Fluid transfer system, pressure isolation mechanism, injector control mechanism, and method using the same
JP2008000201A (en) * 2006-06-20 2008-01-10 Sumitomo Heavy Ind Ltd Dispensing and administering apparatus for radioactive chemical

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017006637A1 (en) * 2015-07-07 2017-01-12 大塚テクノ株式会社 Infusion set and method for using same
JP2017143851A (en) * 2016-02-15 2017-08-24 株式会社根本杏林堂 Clamp, closing device, and medical liquid circuit
CN107638610A (en) * 2017-09-22 2018-01-30 深圳市信冠机电有限公司 A kind of automatic injection system
WO2019187690A1 (en) * 2018-03-29 2019-10-03 テルモ株式会社 Infusion device and syringe pump
CN111601628A (en) * 2018-03-29 2020-08-28 泰尔茂株式会社 Infusion device and syringe pump
JP7102203B2 (en) 2018-04-20 2022-07-19 株式会社メテク Infusion circuit
JP2019187606A (en) * 2018-04-20 2019-10-31 株式会社メテク Infusion circuit
WO2020004581A1 (en) * 2018-06-29 2020-01-02 株式会社サーキュラス Medicinal liquid injecting device
JP7304347B2 (en) 2018-06-29 2023-07-06 株式会社サーキュラス chemical injector
WO2020158830A1 (en) * 2019-01-29 2020-08-06 株式会社サーキュラス Opening/closing unit drive mechanism for drug solution circuit, and drug solution injection device
EP3919098A4 (en) * 2019-01-29 2022-10-05 Circulus Inc. Opening/closing unit drive mechanism for drug solution circuit, and drug solution injection device
JPWO2020158830A1 (en) * 2019-01-29 2021-11-25 株式会社サーキュラス Opening and closing unit drive mechanism for chemical liquid circuit and chemical liquid injection device
KR20200140073A (en) * 2019-06-05 2020-12-15 가톨릭대학교 산학협력단 Extending Infusion Pump and Method for Using the Same
KR102219766B1 (en) * 2019-06-05 2021-02-23 가톨릭대학교 산학협력단 Extending Infusion Pump and Method for Using the Same
WO2020246821A3 (en) * 2019-06-05 2021-01-21 가톨릭대학교 산학협력단 Extensible drug injection device and operation method therefor
US11229750B2 (en) 2020-04-06 2022-01-25 Veloject, Llc Injection device
US11565055B2 (en) 2020-04-06 2023-01-31 Veloject, Llc Injection device
US11590292B2 (en) 2020-04-06 2023-02-28 Veloject, Llc Injection device
WO2023199993A1 (en) * 2022-04-14 2023-10-19 株式会社根本杏林堂 Medical liquid injection device

Also Published As

Publication number Publication date
JPWO2014104338A1 (en) 2017-01-19
JP2018167058A (en) 2018-11-01
JP2020073119A (en) 2020-05-14

Similar Documents

Publication Publication Date Title
JP2018167058A (en) Liquid medicine circuit and liquid medicine circuit system using the same
JP6316924B2 (en) Medical liquid circuit kit and liquid circuit system using the same
US9764081B2 (en) Fluid path containing a pressure isolation valve
JP6002039B2 (en) System and method for assessing the function of a double check valve arrangement in a medical tubing set
US11033676B2 (en) Drug delivery device and method for connecting a fluid flowpath
JP2017185293A (en) Continuous multi-fluid pump device, drive and actuating system, and method
CN105916542B (en) Multi-dose disposable system
JP4769196B2 (en) Controller device
US11826541B2 (en) Sliding syringe cap for separate filling and delivery
US20070244437A1 (en) Fluid delivery system with bulk container and pump assembly
JP4902096B2 (en) Chemical syringe
JP4338446B2 (en) Chemical injection device
CN108601889B (en) Intermittent infusion device
JPWO2018181270A1 (en) Chemical circuit, injection system, and closure mechanism
JP2012507364A (en) Mating mechanism for pressurizing unit and corresponding sleeve in medical fluid injection device
US20070250008A1 (en) Fluid injection apparatus and adaptor pump therefor
WO2010054345A1 (en) Patency check device
JP2017143851A (en) Clamp, closing device, and medical liquid circuit

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13867280

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014554610

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13867280

Country of ref document: EP

Kind code of ref document: A1